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Abstract	  In	   Namibia,	   where	   reduced	   aid	   from	   international	   organizations	   has	   adversely	   affected	  access	   to	  healthcare,	   the	  private	  sector	  needs	   to	   increase	   their	   involvement	   in	  workplace	  health	  and	  wellness.	  We	  helped	  the	  Namibian	  Business	  Coalition	  on	  AIDS	  develop	  a	  cost-­‐benefit	   projection	   model,	   which	   evaluates	   the	   cost-­‐effectiveness	   of	   workplace	   wellness	  programs.	   To	   achieve	   this,	   we	   identified	   Namibia’s	   prevalent	   health	   problems	   and	  determined	  possible	  health	  interventions.	  The	  model	  allows	  companies	  to	  make	  informed	  business	  decisions	  about	  investing	  in	  employee	  wellness.	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Executive	  Summary:	  Establishing	   effective	   healthcare	   systems	   has	   proved	   to	   be	   a	   difficult	   task	  worldwide.	   In	  Africa	   specifically,	   one	   of	   the	   greatest	   challenges	   is	   making	   healthcare	   more	   accessible.	  Namibia,	   a	   country	   that	   has	   recently	   been	   reclassified	   as	   a	  middle-­‐income	   country,	   faces	  the	   challenge	   of	   limited	   accessibility	   as	   well	   as	   reduced	   health-­‐related	   funding	   from	  international	   donors.	   One	   step	   toward	   improving	   the	   healthcare	   situation	   in	   Namibia	   is	  greater	   private	   sector	   support	   through	   the	   implementation	   of	   workplace	   wellness	  programs.	  To	   inform	  Namibian	   companies	   that	  healthcare	   can	  also	  be	  a	  worthy	   financial	  investment,	   a	   cost-­‐benefit	   projection	   model	   can	   be	   used	   to	   quantify	   the	   benefits	   of	  workplace	  wellness	  programs.	  	  
Devoted	   to	   advocating	   the	   importance	   of	   workplace	   wellness	   programs	   to	   Namibian	  companies,	  the	  Namibia	  Business	  Coalition	  on	  AIDS	  (NABCOA),	  in	  close	  collaboration	  with	  the	   Gesellschaft	   für	   Internationale	   Zusammenarbeit	   (GIZ),	   has	   begun	   developing	   a	   cost-­‐benefit	  projection	  model	  that	  conveys	  the	  cost-­‐effectiveness	  of	  these	  programs,	  also	  known	  as	   health	   interventions.	   The	  model	   calculates	   the	   economic	   benefits	   of	   interventions	   by	  determining	   projected	   employee	   absenteeism	   and	   presenteeism,	   which	   is	   when	   health	  issues	   adversely	   affect	   employee	   productivity	   when	   present	   at	   work.	   The	   goal	   of	   our	  project	  was	  to	  further	  develop	  NABCOA’s	  cost-­‐benefit	  projection	  model	  by:	  
1. Creating	  an	  epidemiological	  profile	  that	   identifies	  the	  most	  prevalent	  health	  issues	  for	  the	  Namibian	  working	  population	  2. 	  Determining	   the	   key	   information	   needed	   in	   order	   to	   apply	   and	   evaluate	   desired	  health	  interventions	  within	  the	  model.	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Developing	  the	  Model	  The	  epidemiological	  profile	  was	  comprised	  of	   three	  sections:	   the	   top	  causes	  of	  mortality,	  referring	   to	   death,	   morbidity,	   referring	   to	   sickness,	   and	   risk	   factors,	   behaviors	   or	  conditions	   that	   can	   lead	   to	  serious	  health	  problems.	  We	  calculated	   the	   incidence	  rates	  of	  each	   cause	   of	  mortality	   and	  morbidity	   and	   the	  prevalence	   rates	   of	   each	   risk	   factor.	  Data	  from	  the	  Ministry	  of	  Health	  and	  Social	  Services	  (MoHSS)	  revealed	  that	  the	  top	  three	  causes	  of	  mortality	  for	  males	  and	  females	  included	  HIV/AIDS,	  tuberculosis,	  and	  pneumonia,	  while	  the	  top	  three	  causes	  of	  morbidity	   included	  musculoskeletal	  system	  disorders,	  respiratory	  diseases,	   and	   trauma.	  We	  obtained	   two	   sets	   of	   data	   for	   risk	   factors:	   one	   from	   the	  World	  Health	   Organization	   (WHO)	   Global	   Health	   Observatory,	   and	   the	   other	   from	   Bophelo!	  Mobile	   Wellness	   Screenings	   test	   results.	   These	   rates	   for	   mortality,	   morbidity,	   and	   risk	  factors	  were	  used	  to	  develop	  Namibia’s	  epidemiological	  profile	  for	  the	  projection	  model.	  	  
To	  develop	  a	  better	  understanding	  of	  existing	  interventions,	  we	  obtained	  information	  from	  the	   World	   Health	   Organization	   CHOosing	   Interventions	   that	   are	   Cost	   Effective	   (WHO-­‐CHOICE)	  project,	  NABCOA,	  and	  the	  Walvis	  Bay	  Corridor	  Group	  (WBCG).	  We	  discovered	  that	  most	   of	   the	   WHO-­‐CHOICE	   interventions	   involve	   medical	   treatments,	   which	   realistically	  cannot	   be	   provided	   in	   the	   workplace,	   but	   that	   programs	   such	   as	   peer	   education	   and	  wellness	  screenings	  could	  be	  possible	  interventions	  used	  in	  the	  model.	  Generally,	  we	  found	  that	   interventions	   will	   vary	   based	   on	   company	   size	   and	   location,	   making	   it	   difficult	   to	  determine	  a	  standard	  cost	  that	  would	  apply	  to	  all	  companies.	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We	   introduced	   our	   cost-­‐benefit	   projection	   model	   to	   several	   stakeholders	   at	   discussion-­‐based	   workshops,	   where	   we	   evaluated	   the	   strengths	   and	   weaknesses	   of	   the	   data	   we	  collected.	  The	  following	  points	  were	  considered	  and	  agreed	  upon:	  
• Gender-­‐specific	   data	   is	   very	   important	   for	   the	   epidemiological	   profile	   to	   make	  accurate	   estimates,	   and	   so	   the	  morbidity	   section	   should	   be	   updated	  when	   gender	  specific	  data	  becomes	  available.	  	  
• The	   health	   problems	   identified	   in	   the	   profile	   should	   be	   as	   specific	   as	   possible	   to	  allow	   users	   to	   determine	  which	   problems	   need	   to	   be	   addressed	   in	   interventions.	  Research	  should	  be	  conducted	  to	  define	  any	  broad	  categories.	  
• The	   risk	   factor	   dataset	   from	  Bophelo!	  wellness	   screening	   test	   results	   represented	  the	  Namibian	  working	  population	  best,	  as	  they	  were	  data	  directly	  obtained	  from	  test	  results	  rather	  than	  estimation.	  	  
• Wellness	  managers	  will	  be	  the	  primary	  source	  of	  adding	  interventions	  to	  the	  model,	  as	  they	  are	  most	  aware	  of	  their	  company’s	  health	  situation	  and	  needs.	  
Recommendations	  Based	  on	  these	  findings,	  we	  developed	  several	  recommendations.	  We	  encourage	  NABCOA	  to	   work	   with	   the	   MoHSS	   to	   improve	   data	   collection	   standards	   so	   that	   data	   is	   gender-­‐specific	   and	   the	   health	   problems	   are	   clearly	   defined.	   If	   possible,	   a	   project	   between	  NABCOA,	   GIZ,	   and	   the	   MoHSS	   to	   merge	   all	   sixty-­‐one	   of	   the	   Ministry’s	   databases	   would	  allow	   all	   data	   to	   be	   easily	   accessible	   in	   one	   location.	   To	   maintain	   the	   credibility	   of	   the	  model,	   it	   is	  necessary	  to	  update	  the	  epidemiological	  profile	  regularly	  to	  ensure	  Namibia’s	  health	   situation	   is	   represented	   accurately.	   During	   the	   piloting	   process	   of	   the	  model,	   we	  recommend	   NABCOA	   check	   in	   monthly	   with	   the	   pilot	   companies	   to	   ensure	   that	   any	  
xv	  	  
problems	  are	  addressed,	  the	  success	  of	  interventions	  are	  monitored	  appropriately,	  and	  that	  no	   data	   is	   lost	   throughout	   the	   process.	  We	   also	   recommend	   that	   regional,	   industry,	   and	  sector	   specific	   data	   be	   collected	   as	   available	   so	   that	   the	   model	   can	   be	   adapted	   more	  specifically	  to	  companies	  in	  the	  future.	  	  
With	  the	  completion	  of	  this	  cost-­‐benefit	  projection	  model,	  companies	  will	  be	  able	  to	  use	  the	  tool	   to	   make	   informed	   business	   decisions	   when	   considering	   whether	   to	   implement	  workplace	  wellness	   programs.	  Once	  wellness	  managers	   enter	   company-­‐specific	   data,	   the	  projection	  model	  will	   clearly	   convey	  which	   health	   problems	   have	   the	   biggest	   impact	   on	  productivity	   and	   can	   be	   addressed	  with	   cost-­‐effective	   interventions.	   By	   illustrating	   how	  companies	  can	  benefit	  financially	  from	  implementing	  wellness	  programs	  in	  the	  workplace,	  the	  model	  has	  the	  potential	  to	  increase	  the	  number	  of	  companies	  that	  offer	  health-­‐related	  services	  to	  their	  employees	  and	  simultaneously	  improve	  both	  the	  health	  of	  employees	  and	  the	  productivity	  of	  businesses.	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Chapter	  1:	  Introduction	  In	   recent	   years,	   countries	   throughout	   Africa	   have	   encountered	   challenges	   providing	  healthcare	   services	   to	   prevent	   and	   treat	   a	   multitude	   of	   diseases	   (Rundell,	   2010).	   While	  HIV/AIDS	  has	  been	  a	  major	  health	  issue	  and	  the	  focus	  of	  many	  advocacy	  campaigns,	  there	  are	   numerous	   other	   health	   problems,	   including	   pneumonia,	   diabetes,	   and	   high	   blood	  pressure,	   that	   also	   require	   treatment,	  medications	  and	  diagnostic	   technologies	  not	   easily	  accessible	   or	   affordable	   in	  many	   regions	   of	   the	   continent.	  A	   greater	   emphasis	   on	  overall	  healthcare	   and	   prevention	   to	   achieve	   better	   health	   and	  wellness	   is	   being	   developed	   and	  advocated	  in	  many	  countries.	  
Namibia	   specifically	   faces	   two	   main	   healthcare	   challenges.	   Due	   to	   the	   country’s	   vast	  geography	  and	  scattered	  population,	  accessibility	   to	  healthcare	   is	   limited.	  There	   is	  also	  a	  growing	  need	  for	  self-­‐sustainability	  as	  a	  result	  of	  reductions	  in	  international	  health-­‐related	  donors	   after	   being	   reclassified	   as	   an	   upper-­‐middle	   income	   country.	   In	   response	   to	   these	  challenges,	   the	   private	   sector	   has	   begun	   investing	   and	   showing	   interest	   in	   employee	  healthcare.	   Organizations	   like	   the	   Namibia	   Business	   Coalition	   on	   AIDS	   (NABCOA)	   work	  with	  businesses	  to	  increase	  wellness	  services	  in	  the	  workplace.	  While	  NABCOA	  encourages	  member	  companies	  to	  participate	  in	  their	  workplace	  wellness	  programs,	  not	  all	  companies	  decide	  to	  make	  the	  investment,	  meaning	  that	  employees	  who	  could	  potentially	  benefit	  from	  the	  support	  of	  wellness	  programs	  may	  not	  have	  access	  to	  them.	  
Other	   countries	   in	  Africa	  have	  made	  progress	   in	  providing	  quality	  healthcare	   services	   to	  their	  populations.	  South	  Africa	  and	  Rwanda	  have	  established	  universal	  healthcare	  systems	  to	   make	   health	   services	   more	   readily	   available	   (Rundell,	   2010).	   In	   Nigeria	   and	   Ghana,	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organizations	  are	  working	  to	  support	  programs	  that	  increase	  the	  accessibility	  of	  healthcare	  in	   isolated	   regions	   (Hygeia	  Nigeria,	   2013;	  Rural	  Healthcare,	   2012).	   In	  Ghana,	  Kenya,	   and	  Tanzania,	   a	   cost-­‐benefit	  projection	  model	  has	  been	  used	  by	   the	  private	   sector	   to	   identify	  the	   most	   prevalent	   health	   concerns	   in	   the	   working	   population	   and	   to	   evaluate	   the	  economic	  benefits	  of	   implementing	  workplace	   interventions.	  This	  has	  resulted	  in	  a	   larger	  number	  of	  companies	   in	   these	  countries	  recognizing	   the	   financial	  benefits	  of	   investing	   in	  workplace	  wellness	  programs.	  	  
It	  is	  likely	  that	  the	  economic	  benefits	  of	  investing	  in	  workplace	  programs	  have	  never	  been	  clearly	  conveyed	  to	  Namibian	  companies	  in	  a	  comprehensive	  and	  credible	  manner.	   	  If	  the	  financial	   advantages	  of	  workplace	  wellness	  programs	  were	   fully	  explained	   to	   companies,	  they	   could	   understand	   why	   it	   would	   be	   a	   good	   business	   decision	   to	   increase	   their	  investment	   in	  healthcare.	   In	  an	  effort	   to	   inform	  companies	  of	   these	  advantages,	  NABCOA	  has	   begun	   developing	   a	   Return	   on	   Investment	   Toolkit	   that	   advocates	   for	   wellness	  programs	  and	  makes	  a	  cost-­‐benefit	  projection	  model	  available	  for	  use	  by	  the	  private	  sector.	  
Our	  goal	  was	  to	  aid	  NABCOA	  in	  developing	  the	  cost-­‐benefit	  projection	  model	  component	  of	  their	  Return	  on	  Investment	  Toolkit.	  Using	  the	  model,	  Namibian	  companies	  will	  be	  able	  to	  estimate	  the	  cost-­‐effectiveness	  of	  workplace	  wellness	  programs.	  We	  accomplished	  our	  goal	  by	   populating	   the	   model	   with	   Namibia-­‐specific	   epidemiological	   data	   and	   identifying	  possible	   health	   interventions	   that	   can	   be	   evaluated	   using	   the	   model.	   The	   successful	  introduction	  of	  this	  cost-­‐benefit	  projection	  model	  has	  the	  potential	  to	  allow	  companies	  to	  make	   an	   informed	   decision	   when	   considering	   whether	   or	   not	   to	   invest	   in	   a	   workplace	  wellness	   program.	   Conveying	   the	   financial	   benefits	   of	   these	   programs	   could	   lead	   to	   an	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Chapter	  2:	  Background	  To	   provide	   an	   understanding	   of	   the	   challenges	   associated	   with	   providing	   healthcare	   in	  Africa,	   this	   chapter	   describes	   features	   of	   healthcare	   systems	   worldwide	   and	   in	   various	  African	   countries.	   We	   then	   discuss	   challenges	   specific	   to	   Namibia	   with	   respect	   to	  healthcare	  and	   international	   funding,	  and	  how	  the	  Namibia	  Business	  Coalition	  on	  AIDS	   is	  looking	  to	  make	  improvements	  in	  its	  healthcare	  outreach	  operations.	  
2.1	  Healthcare	  Worldwide	  Countries	   tend	   to	   provide	   healthcare	   services	   to	   their	   populations	   in	   ways	   that	   are	  compatible	  with	  their	  economic,	  political,	  and	  social	  structures.	  For	  example,	  England	  has	  universal	  healthcare	  under	  the	  National	  Health	  Service	  (NHS)	  plan	  (Thomson	  et	  al.,	  2011).	  Citizens	   only	   pay	   partial	   costs	   for	   some	   prescriptions	   and	   some	   dental	   care,	   while	   the	  government	   provides	   all	   primary	   care,	   specialist	   care,	   and	   hospital	   services.	   English	  residents	   receive	  broad	  healthcare	   that	   is	   funded	   through	   taxes,	   and	  people	  who	  are	  not	  residents	   receive	   free	   treatment	   for	   accidents	   and	   emergency	   care	   for	   some	   infectious	  diseases.	   The	   NHS	   focuses	   on	   improving	   any	   problems	   there	   may	   be	   in	   the	   public	  healthcare	  system.	  
France	   also	   has	   universal	   healthcare	   (Thomson	   et	   al.,	   2011).	   Similar	   to	   England,	   all	  residents	   in	  France	   receive	  healthcare	  provided	  by	   the	  Statutory	  Health	   Insurance	   (SHI),	  which	  is	  also	  financed	  publicly	  through	  taxes.	  However,	  not	  all	  costs	  are	  covered	  by	  the	  SHI.	  Hospital	  care,	  ambulatory	  care,	  and	  prescriptions	  are	  free	  for	  the	  country’s	  population,	  but	  dental	   care	   and	  outpatient	   vision	   services	   are	  not	   fully	   covered.	   Preventative	   care	   is	   not	  initially	  covered	  by	  the	  SHI	  but	  can	  eventually	  be	  reimbursed.	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Healthcare	   in	   the	  United	  States	   is	  provided	  by	  private	   and	  public	   insurance	  plans	   (Chua,	  2006).	   Unlike	   England	   and	   France,	   private	   insurance	   companies	   are	   the	   dominant	  providers	   of	   healthcare	   coverage	   in	   the	  United	   States,	   as	  most	  people	   receive	  healthcare	  through	   their	   employers.	   The	  main	   public	   systems	   include	   Medicare,	   a	   federal	   program	  that	  covers	  people	  over	  the	  age	  of	  65,	  and	  Medicaid,	  a	  program	  that	  covers	  low-­‐income	  and	  disabled	   populations.	   There	   are	   also	   public	   healthcare	   systems	   that	   cover	   government	  employees	  as	  well	  as	  veterans.	  While	  the	  different	  healthcare	  systems	  in	  the	  United	  States	  cover	  a	   large	  portion	  of	   the	  American	  population,	   there	  are	  problems	  that	  have	   led	   to	  an	  emerging	   need	   for	   healthcare	   reform	   (Vortruba,	   2010).	   The	   United	   States	   spends	   about	  double	   per	   capita	   on	   healthcare	   compared	   to	   other	   developed	   countries.	   Medicare	   and	  Medicaid	  are	  also	  financially	  unsustainable	  because	  healthcare	  costs	  are	  rising	  faster	  than	  the	  rate	  of	  productivity	  growth.	  These	  rising	  costs	  are	  causing	  an	  inequality	  of	  healthcare	  services	   throughout	   different	   regions	   of	   the	   country.	   Lastly,	   it	   can	   be	   difficult	   for	   many	  people	  to	  afford	  and	  access	  healthcare	  in	  the	  United	  States,	  especially	  for	  those	  who	  do	  not	  receive	  health	  insurance	  from	  their	  employer.	  	  
Depending	   on	   a	   country’s	   circumstances,	   healthcare	   can	   be	   often	   provided	   in	   different	  ways.	   Some	   countries	   have	   universal	   healthcare,	   such	   as	   England	   and	   France,	   while	   the	  citizens	  of	  other	  countries	  receive	  more	  healthcare	  through	  the	  private	  sector,	   like	   in	   the	  United	   States.	   Although	   differing	   in	   some	   respects,	   healthcare	   systems	   in	   developed	  countries	  often	  share	  similar	  characteristics.	  For	  example,	  these	  systems	  are	  generally	  self-­‐sustainable	   and	   aim	   to	   be	   accessible	   to	   the	   whole	   population.	   	   Countries	   in	   developing	  parts	  of	   the	  world,	   such	  as	  Africa,	   strive	   to	   structure	   their	  healthcare	   systems	   to	  achieve	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similar	   goals.	   In	   the	   next	   section	   we	   will	   describe	   some	   specifics	   of	   African	   healthcare	  systems.	  
2.2	  Healthcare	  in	  Africa	  Africa	  is	  a	  very	  diverse	  continent	  where	  each	  country	  has	  different	  cultures,	  governments,	  and	   social	   structures.	   Health	   challenges	   also	   vary	   throughout	   the	   continent,	   but	   many	  countries	  are	   confronting	   several	  health	  problems,	   including	  HIV/AIDS,	   tuberculosis,	   and	  non-­‐communicable	   diseases	   such	   as	   diabetes	   and	   cardiovascular	   disease.	   To	   provide	  adequate	   treatment	   to	   the	   millions	   of	   people	   affected	   by	   these	   diseases,	   healthcare	  programs	   should	   be	   easily	   accessible.	   In	   2007,	   the	   financial	   management	   corporation	  Merrill	  Lynch	  reported	  that	  healthcare	  was	  to	  be	  one	  of	  the	  most	  promising	  investments	  in	  Africa	  (Rundell,	  2010).	  Due	  to	  the	  high	  rates	  of	  infection	  from	  diseases	  like	  HIV/AIDS,	  the	  life	  expectancy	  of	  people	  living	  in	  Sub-­‐Saharan	  African	  countries	  decreased	  from	  62	  years	  to	  47	  years	  between	  1990	  and	  2005	  (Uwah	  &	  Ebewo,	  2011).	  Many	  African	  countries	  are	  also	  working	  toward	  being	  economically	  self-­‐sufficient	  and	  not	  requiring	  international	  aid.	  With	  these	  goals	  in	  mind,	  there	  is	  potential	  for	  healthcare	  systems	  to	  improve	  considerably,	  and	  the	  public	  and	  private	  sectors	  of	  countries	  in	  Africa	  have	  been	  taking	  on	  different	  roles	  to	  address	  these	  challenges.	  
2.2.1	  Public	  and	  Private	  Sector	  Roles	  in	  Healthcare	  The	   public	   sector	   consists	   of	   organizations	   that	   are	   owned	   and	   managed	   by	   the	  government,	   while	   the	   private	   sector	   is	   composed	   of	   companies	   and	   non-­‐profit	  organizations	   that	   operate	   financially	   independently	   from	   the	   government	   (Rundell,	  2010).	   	  While	   in	  many	  countries	   the	  government	  may	  not	  have	   the	  means	   to	  provide	   the	  funds	   necessary	   to	   implement	   healthcare	   services	   on	   a	   large	   scale,	   an	   objective	   for	   the	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future	  is	  the	  establishment	  of	  some	  kind	  of	  universal	  healthcare	  system	  (Knijn	  &	  Slabbert,	  2012;	   Mayosi	   et	   al.,	   2012).	   African	   countries	   that	   have	   already	   achieved	   universal	  healthcare	  include	  South	  Africa	  and	  Rwanda.	  The	  South	  African	  government	  provides	  a	  flat-­‐rate	  basic	  plan	  of	  “R800	  a	  month	  for	  an	  individual	  and	  R2,000	  for	  a	  family,	  regardless	  of	  age	  or	  state	  of	  health”	  (Rundell,	  2010,	  para.	  27).	  Rwanda	  has	  had	  national	  health	  insurance	  for	  eleven	  years,	  successfully	  providing	  coverage	  to	  92%	  of	  the	  country’s	  population.	  
Many	  African	  countries	  have	  healthcare	  programs	  sponsored	  by	  the	  private	  sector.	  On	  the	  role	  of	  the	  private	  sector	  in	  healthcare,	  Sarah	  Rundell	  (2010)	  reports,	  “…of	  the	  $16.7bn	  in	  total	  health	  expenditure	  in	  2005,	  around	  60%	  was	  privately	  financed,	  and	  about	  half	  of	  the	  total	   spent	   went	   to	   private	   providers”	   (para.	   4).	   The	   private	   health	   sector	   has	  “outperformed	  general	  economic	  growth”	  and	  has	  exhibited	  the	  potential	  to	  develop	  even	  more	  (para.	  4).	  In	  Nigeria,	  the	  private	  healthcare	  company	  Hygeia	  Nigeria	  (2013)	  provides	  services	   to	   about	   150,000	   people.	   Since	   its	   establishment	   in	   1986,	   the	   company	   has	  expanded	  to	   include	  Hygeia	  Nigeria	  Limited,	  a	  branch	  that	  manages	  hospitals	  and	  clinics,	  and	  the	  Hygeia	  Community	  Health	  plan,	  which	  is	  a	  donor	  funded	  initiative	  to	  make	  quality	  healthcare	   more	   accessible	   to	   low	   income	   populations	   of	   Nigeria.	   In	   Ghana,	   a	   local	  organization,	  Medicine	  on	  the	  Move,	  trains	  women	  to	  build,	  maintain,	  and	  pilot	  aircrafts	  to	  supply	   isolated	   rural	   areas	   of	   the	   country	   with	   resources	   to	   help	   prevent	   the	   parasitic	  infection	  Schistosomiasis	  (Rural	  Healthcare,	  2012).	  	  
The	   private	   sectors	   in	  many	   countries	   continue	   to	   become	  more	   involved	   in	   healthcare.	  One	   way	   some	   countries	   are	   achieving	   this	   is	   through	   companies	   offering	   healthcare	  services	   to	   their	   employees,	   similar	   to	   how	   the	   United	   States	   offers	   health	   insurance	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through	   the	  workplace.	  One	   country	   that	   has	   begun	  doing	   this	   is	   Ghana	   (Wilson,	   2012.),	  where	   the	   Ministry	   of	   Health	   has	   worked	   to	   promote	   employee	   wellbeing	   programs	   in	  many	  companies	  to	  increase	  the	  private	  sector’s	  role	  in	  healthcare.	  The	  programs	  consist	  of	  services	   such	  as	  educational	  programs,	  health	   screenings,	   and	  health	   insurance.	  Not	  only	  have	   these	   wellbeing	   programs	   improved	   healthcare	   in	   Ghana	   and	   the	   private	   sector’s	  involvement,	   but	   they	   have	   also	   improved	   business	   productivity	   through	   healthier	  employees.	  While	   these	  programs	  alone	  are	  making	  healthcare	  more	  accessible,	  both	   the	  private	  and	  public	  sectors	  continue	  to	  be	  involved	  with	  healthcare	  in	  African	  countries.	  
2.2.2	  Public-­‐Private	  Partnerships	  In	  some	  cases	  the	  public	  and	  private	  sectors	  have	  combined	  their	  resources	  through	  public-­‐private	   partnerships.	   One	   example	   is	   in	   Lesotho,	   where	   South	   Africa’s	   biggest	   private	  healthcare	   company,	   Netcare,	   the	   Development	   Bank	   of	   South	   Africa,	   and	   the	   Lesotho	  government	  came	  together	  to	  build	  a	  new	  hospital	  building	  (Rundell,	  2010).	  The	  hospital,	  a	  $100	  million	  dollar,	  425-­‐bed	  building,	  was	  the	  first	  hospital	  built	  in	  Lesotho	  in	  fifty	  years.	  It	  has	   eight	   well-­‐equipped	   operating	   rooms,	   an	   intensive	   care	   unit,	   and	   a	   laboratory.	   The	  partnership	  was	  structured	  so	  that	  the	  Lesotho	  government	  will	  gradually	  “buy	  back”	  the	  hospital	   from	  Netcare	  over	   the	  next	   eighteen	  years.	  While	   initially	  Netcare	  and	   the	  Bank	  fronted	   the	   funds	   to	   build	   the	   new	   facility,	   the	   partnership	   was	   arranged	   so	   that	   the	  government	  would	  eventually	  have	  control	  of	  a	  modern,	  highly	  functional	  medical	  facility.	  
2.2.3	  Problems	  with	  African	  Healthcare	  One	  of	  the	  greatest	  challenges	  associated	  with	  African	  healthcare	  is	  its	  accessibility.	  Many	  countries	  in	  Africa	  are	  still	  developing	  working	  healthcare	  systems,	  and	  may	  not	  have	  the	  highest	   quality	  health	   services.	  Numerous	   countries	  have	  been	   addressing	   this	   issue	   and	  
9	  	  
making	   improvements	   to	   their	   healthcare	   systems.	   To	   help	   with	   this	   goal	   of	   improving	  their	   healthcare	   systems,	   countries	   often	   receive	   financial	   donations	   from	   international	  organizations.	   Some	   of	   these	   organizations	   include	   The	   Global	   Fund	   to	   fight	   AIDS,	  Tuberculosis,	   and	   Malaria	   (GFATM),	   the	   Joint	   United	   Nations	   Programme	   on	   HIV/AIDS	  (UNAIDS),	   the	   U.S.	   President’s	   Emergency	   Plan	   for	   AIDS	   Relief	   (PEPFAR),	   the	   Bill	   and	  Melinda	  Gates	  Foundation,	  and	  more.	  	  
Receiving	   aid	   from	   these	   international	   organizations	   leads	   to	   another	   challenge	   with	  healthcare	  in	  many	  countries.	  Over	  time,	  countries	  may	  develop	  a	  financial	  dependency	  on	  these	   organizations,	   leading	   to	   healthcare	   systems	   that	   are	   unable	   to	   be	   self-­‐sufficient	  without	   international	   aid	   (Grogan,	   2012.)	   Funding	   from	   donors	   may	   eventually	   be	  discontinued,	  and	  many	  of	  these	  systems	  will	  need	  to	  be	  able	  to	  provide	  quality	  healthcare	  without	  outside	  support.	  These	  two	  issues	  are	  common	  for	  a	  number	  of	  countries	  in	  Africa,	  and	   the	   private	   and	   public	   sectors	   could	   play	   an	   important	   role	   in	   developing	   self-­‐sustainability	  through	  an	  increased	  investment	  in	  healthcare.	  
2.3	  Healthcare	  in	  Namibia	  Namibia	  is	  one	  of	  the	  many	  countries	  in	  Africa	  that	  has	  a	  high	  prevalence	  of	  diseases	  such	  as	   HIV/AIDS,	   as	   well	   as	   non-­‐communicable	   diseases	   (Guariguata	   et	   al.,	   2012).	   It	   can	   be	  difficult	   for	   many	   Namibians	   to	   afford	   and	   access	   high-­‐quality	   healthcare,	   as	   many	  healthcare	   services	   and	   clinics	   that	   most	   people	   can	   access	   are	   lower	   quality	   due	   to	  facilities	  being	  overcrowded	  and	  understaffed.	  Focused	  on	  combating	  the	  spread	  of	   these	  health	  system	  problems,	  Namibia	  has	  been	  proactive	  in	  its	  efforts	  to	  improve	  its	  healthcare	  system.	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Health	   reform	   has	   been	   a	   priority	   for	   the	   Namibian	   government	   since	   the	   country’s	  independence	   in	   1990	   (World	   Health	   Organization,	   2010).	   Overall,	   there	   has	   been	   an	  increase	   in	   the	   number	   of	   people	   able	   to	   obtain	   some	   healthcare	   coverage,	   a	   result	   of	  efforts	  made	  by	  public	  and	  private	  health	  sectors.	  	  
The	   Namibian	   public	   health	   system	   is	   controlled	   by	   the	   government,	   specifically	   the	  Ministry	  of	  Health	  and	  Social	  Services	  (MoHSS),	  and	  consists	  of	  1,150	  outreach	  points,	  265	  clinics,	   44	   health	   centers,	   30	   district	   hospitals,	   3	   intermediate	   hospitals,	   and	   1	   national	  referral	  hospital	  (Brockmeyer,	  2012;	  World	  Health	  Organization,	  2010).	  The	  public	  health	  sector	   is	   structured	   so	   that	   authority	   is	   divided	   among	   13	  MoHSS	   regional	   directorates,	  which	  oversee	  34	  districts.	  While	  only	  8.5%	  of	  the	  Namibian	  population	  is	  publicly	  insured,	  public	  hospitals	  provide	  care	   to	   the	  majority	  of	   the	  Namibian	  population.	  This	   is	  because	  public	  hospitals	  provide	  consultations	  for	  all	  of	  the	  population,	  including	  the	  83%	  who	  are	  uninsured	   (Mbapaha,	   2011).	  According	   to	  Brockmeyer	   (2012),	   the	  MoHSS	   is	  working	   on	  structuring	   the	   public	   healthcare	   system	   so	   that	   “everybody	   can	   have	   access	   to	   public	  healthcare,	  even	  if	   they	  are	  not	  able	  to	  pay,	  but	  those	  who	  are	  able	  to	  pay	  should	  pay	  for	  health	  services”	  (p.	  3).	  
The	  private	  health	  sector	  consists	  of	  844	  private	  health	  facilities,	  557	  medical	  practitioners,	  and	  75	  pharmacies	   (World	  Health	  Organization,	   2010).	  There	   are	  13	  private	  hospitals,	   8	  private	   health	   centers,	   and	   75	   private	   primary	   care	   clinics.	   The	   private	   health	   sector	   is	  financed	   largely	  by	  private,	  non-­‐profit	  medical	  aid	   funds	  and	  provides	  care	  mainly	   to	   the	  middle/high	  income	  population,	  approximately	  8.5%	  of	  the	  total	  population	  (Brockmeyer	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2012;	   Mbapaha,	   2011).	   For	   many	   Namibians,	   especially	   low-­‐income	   workers,	   accessing	  private	  healthcare	  is	  difficult	  because	  of	  financial	  limitations	  (Brockmeyer,	  2012).	  
Faith-­‐Based	   Organizations	   (FBOs)	   and	   Non-­‐Governmental	   Organizations	   (NGOs)	   play	   a	  large	   role	   in	   promoting	   health	   and	   social	   welfare	   in	   communities	   (World	   Health	  Organization,	   2010).	   Many	   NGOs	   focus	   on	   diseases	   like	   HIV/AIDS,	   Malaria,	   and	  Tuberculosis,	   and	   receive	   financial	   donations	   from	   organizations	   such	   as	   PEPFAR,	   and	  GFATM	  to	  operate	  their	  programs	  (Brockmeyer,	  2012).	  
After	   analyzing	   the	   quality	   and	   success	   of	   the	   Namibia’s	   health	   systems,	   the	  Ministry	   of	  Health	   and	   Social	   Services	   (MOHSS)	   (2008)	   recognized	   several	   weaknesses.	   One	   of	   the	  greatest	  healthcare	  challenges	   is	  accessibility	  (World	  Health	  Organization,	  2010;	  Ministry	  of	  Health	   and	   Social	   Services,	   2008).	   The	   geography	   of	   the	   country	  makes	   it	   difficult	   for	  many	  Namibians	   to	   travel	   the	   long	  distances	   to	  clinics.	   In	  a	  study	   from	  2008,	   the	  MOHSS	  found	   that	  of	  295	  people	   interviewed	  while	   leaving	  a	  health	   facility,	  41.5%	  had	   travelled	  less	   than	   5	   kilometers,	   27%	   had	   travelled	   5-­‐10	   kilometers,	   8%	   had	   travelled	   11-­‐20	  kilometers,	   and	   13%	   had	   travelled	   a	   distance	   greater	   than	   21	   kilometers.	   	   Finding	   the	  transportation	  to	  travel	  longer	  distances	  to	  clinics	  can	  be	  difficult	  for	  many	  people	  in	  rural	  areas,	  restricting	  accessibility	  to	  healthcare.	  	  
Another	  challenge	  is	  the	  equality	  of	  health	  services	  (Brockmeyer,	  2012).	  	  Inequality	  exists	  between	  urban	  and	  rural	  areas,	  as	  well	  as	  between	  both	  white	  and	  black,	  and	  rich	  and	  poor	  populations.	  The	  issue	  of	   inequality	  of	  health	  services	  is	  related	  to	  the	  challenge	  of	  socio-­‐economic	   inequality.	   For	   example,	   people	  with	   a	  wealthier	  background	  would	  be	   able	   to	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afford	  and	  travel	  to	  better	  quality	  health	  clinics	  while	  those	  who	  do	  not	  have	  the	  financial	  means	  may	  only	  be	  able	  to	  access	  a	  low-­‐quality	  health	  service.	  	  
Namibia’s	   economic	   situation	   poses	   another	   challenge	   for	   healthcare.	   Economically,	  Namibia	  is	  different	  from	  many	  other	  African	  countries,	  as	  it	  is	  now	  classified	  as	  an	  upper-­‐middle	   income	   level	   country	   (The	   World	   Bank,	   2013).	   Because	   of	   this	   classification,	  Namibia	  receives	  a	  substantially	  smaller	  amount	  of	  international	  donor	  support	  for	  health	  and	  wellness	  programs	  than	  other	  African	  countries.	  This	  financial	  challenge	  is	  addressed	  in	  more	  detail	  in	  the	  following	  sections.	  
2.3.1	  Namibia’s	  Reclassification	  as	  an	  Upper-­‐Middle	  Income	  Country	  In	  the	  past	  ten	  years,	  Namibia	  has	  experienced	  a	  dramatic	  change	  in	  its	  economic	  status.	  In	  the	  early	  2000’s,	  Namibia	  was	  classified	  as	  a	  lower-­‐middle	  income	  country	  based	  on	  its	  per	  capita	  gross	  national	   income	  (Gootnick,	  2011).	  Since	  2006,	   the	  gross	  national	   income	  per	  capita	  of	  Namibia	  has	  been	  steadily	  rising,	  increasing	  from	  about	  2,370	  US	  dollars	  in	  2006	  to	  about	  3,360	  US	  dollars	  in	  2009.	  In	  2010,	  however,	  Namibia’s	  increase	  in	  gross	  national	  income	   per	   capita	  was	   greater	   than	   almost	   the	   previous	   three	   years	   combined.	   The	   per	  capita	   income	   rose	   from	  3,360	  US	  dollars	   to	   almost	   4,200	  US	  dollars	   and	   led	  The	  World	  Bank	   to	   officially	   classify	   Namibia	   as	   an	   upper-­‐middle	   income	   country.	   The	   cutoff	   point	  between	  lower-­‐middle	  income	  and	  upper-­‐middle	  income	  was	  at	  about	  3,700	  US	  dollars	  in	  2010.	   Figure	   2.1	   illustrates	   Namibia’s	   increase	   in	   per	   capita	   gross	   national	   income	   and	  identifies	   the	   cutoff	   for	   lower-­‐middle	   income	   status	   and	   upper-­‐middle	   income	   status	   as	  provided	  by	  the	  Millennium	  Challenge	  Corporation	  (MCC).	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  Figure	  2.1:	  GNI	  Per	  Capita	  of	  Namibia	  (Millennium	  Challenge	  Corporation,	  2011,	  p.	  62).	  
Namibia’s	   reclassification	   as	   an	   upper-­‐middle	   income	   country	   is	   perceived	   as	   a	   positive	  advancement;	  however,	  it	  says	  nothing	  about	  the	  distribution	  of	  income	  across	  the	  country	  (Van	   Rooy,	   Roberts,	   Schier,	   Swartz,	   &	   Levine,	   2006).	   The	   uneven	   distribution	   can	   be	  measured	   using	   the	   Gini	   coefficient,	   which	   measures	   the	   inequality	   of	   income	   among	   a	  country’s	  population.	  The	  Gini	   coefficient	   ranges	   from	  0	   to	  1,	  where	  0	  represents	  perfect	  income	   equality	   and	   1	   represents	   complete	   inequality.	   Specifically,	   to	   have	   a	   Gini	  coefficient	  of	  1,	  one	  person	  would	  have	   to	  earn	  all	  of	   the	  country’s	   income	  and	  everyone	  else	  would	  have	  to	  earn	  nothing.	  The	  Gini	  coefficient	   for	  Namibia	   is	  believed	  to	  be	  0.697,	  which	  is	  among	  the	  highest	  in	  the	  world.	  The	  income	  inequality	  and	  the	  reclassification	  of	  Namibia	  as	  an	  upper-­‐middle	   income	  country	  have	   implications	   for	   the	  healthcare	  system	  (Shebaya,	  Sutherland,	  Levine,	  &	  Faden,	  2010).	  For	  example,	  a	  higher	  income	  family	  should	  be	  able	  to	  afford	  healthcare.	  However,	  there	  are	  many	  families	  living	  on	  less	  than	  three	  US	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dollars	   a	   day	  who	   are	   not	   able	   to	   afford	   quality	   healthcare	  without	   donor	   support.	   The	  inequality	  of	  incomes	  in	  Namibia	  indicates	  that	  the	  gross	  national	  income	  per	  capita	  is	  not	  representative	  of	  the	  economic	  standing	  of	  all	  Namibians.	  This	  has	  negatively	  impacted	  the	  Namibian	  healthcare	  system.	  
Due	   to	   Namibia’s	   former	   classification	   as	   a	   lower-­‐middle	   income	   country	   with	   a	   high	  prevalence	  of	  many	  fatal	  diseases,	  the	  country	  received	  assistance	  and	  funding	  from	  many	  international	  organizations	  (O'Hanlon,	  deBeer,	  Feeley,	  Sulzbach,	  &	  Vincent,	  2010).	  Some	  of	  these	  organizations	  include	  GFATM,	  UNAIDS,	  the	  United	  Nations	  Children’s	  Fund	  (UNICEF),	  the	   United	   States	   Agency	   for	   International	   Development	   (USAID),	   PEPFAR,	   and	   more.	  Funding	  from	  these	  organizations	  helped	  Namibia	  make	  significant	  progress	  in	  healthcare	  by	   supporting	   programs	   and	   services	   that	   allow	   treatment	   for	   many	   diseases,	   such	   as	  antiretrovirals	   for	   AIDS	   and	   antibiotics	   for	   tuberculosis.	   However,	   when	   Namibia	   was	  reclassified	   as	   an	   upper-­‐middle	   income	   country,	   the	   funding	   from	   these	   organizations	  decreased	   significantly,	   specifically	   affecting	   non-­‐government	   organizations	   that	   provide	  health	  services.	  
2.3.2	  Namibia’s	  Decrease	  in	  International	  Financial	  Support	  for	  Healthcare	  The	  World	  Bank’s	  reclassification	  of	  Namibia	  as	  an	  upper-­‐middle	  income	  country	  has	  led	  to	  the	  expectation	  for	  the	  country	  to	  take	  on	  a	  greater	  financial	  responsibility	  for	  sustaining	  health	   and	   wellness	   (O'Hanlon	   et	   al.,	   2010).	   A	   decrease	   in	   donations	   from	   many	  international	   organizations	   means	   Namibian	   healthcare	   must	   be	   funded	   from	   different	  sources.	  After	  several	  years	  of	  being	  classified	  as	  a	  lower-­‐middle	  income	  country,	  Namibia	  became	   financially	   dependent	   on	   international	   organizations	   after	   receiving	   a	   greater	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amount	   of	   financial	   support	   (Sulzbach,	  De,	  &	  Wang,	   2011).	  Between	  2001	   and	  2009,	   the	  funding	  received	  from	  international	  organizations	  for	  HIV/AIDS	  programs	  increased	  from	  3.8	  percent	   to	  21.7	  percent,	   leading	   to	  a	   large	  decrease	  of	   funding	   from	  Namibia’s	  public	  and	  private	  sectors.	  The	  public	  and	  private	  sectors	  must	  now	  adjust	  their	  finances	  to	  help	  fund	  more	  healthcare	  programs	  to	  continue	  improving	  the	  general	  health	  of	  the	  population.	  
With	  this	  loss	  of	  healthcare	  system	  funding	  in	  Namibia,	  steps	  have	  been	  taken	  to	  increase	  aid	   from	  the	  private	  sector	  (O'Hanlon	  et	  al.,	  2010).	   	  Some	   international	  organizations	  are	  still	  assisting	  Namibia	  with	  its	  funding	  transition	  by	  educating	  the	  private	  sector	  about	  the	  benefits	   of	   investing	   in	   healthcare.	   For	   example,	   USAID	   sponsors	   a	   project	   called	  Strengthening	  Health	  Outcomes	  through	  the	  Private	  Sector	  (SHOPS).	  The	  project	  seeks	  to	  provide	   funding	   for	  wellness	   and	  HIV/AIDS	   programs,	   and	   aims	   to	   convince	   the	   private	  sector	   that	   investing	   in	   health	   and	   wellness	   is	   profitable.	   Some	   organizations,	   non-­‐governmental	  and	  governmental,	  are	  looking	  to	  gain	  private	  sector	  support	  by	  encouraging	  businesses	  to	  provide	  health	  services	  to	  their	  employees.	  
2.4	  The	  Namibia	  Business	  Coalition	  on	  AIDS	  A	   nongovernmental	   organization	   that	   supports	   health	   and	   wellness	   programs	   in	   the	  workplace	   is	   the	  Namibia	  Business	  Coalition	  on	  AIDS	   (NABCOA)	   (van	  Wyk,	  2008).	  When	  founded,	   NABCOA	   promoted	  mainly	   HIV/AIDS	   programs	   rather	   than	   addressing	   general	  wellness.	  NABCOA	  has	  received	  funding	  from	  many	  of	  the	  international	  organizations	  that	  donate	   to	   healthcare	   services	   in	   Namibia,	   such	   as	   GFATM,	   the	  Deutsche	   Gesellschaft	   für	  Internationale	  Zusammenarbeit	  (GIZ),	  UNAIDS,	  and	  more.	  Of	  these,	  GFATM	  has	  donated	  the	  most	   to	  NABCOA.	  However,	   similar	   to	  many	  other	  healthcare-­‐promoting	  organizations	   in	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Namibia,	   NABCOA	   has	   not	   received	   as	   much	   international	   funding	   since	   Namibia’s	  reclassification	   to	   upper-­‐middle	   income	   status.	   Therefore,	   NABCOA	   now	   needs	   funding	  from	  other	  sources	  inside	  Namibia.	  
NABCOA	  receives	   its	   funding	   from	  the	  membership	   fees	  companies	  pay	   to	  use	  NABCOA’s	  programs,	   revenues	   from	   services,	   and	   donations	   from	   international	   organizations	   (van	  Wyk,	  2008).	   In	  2008,	   only	  80,000	  US	  dollars	  of	  NABCOA’s	   funding	  was	   received	   through	  membership	   fees	   and	   revenues	   from	   services,	   while	   360,000	   US	   dollars	   of	   NABCOA’s	  funding	  was	  from	  international	  donors.	  
NABCOA	  is	  now	  looking	  for	  more	  funding	  from	  Namibia’s	  private	  sector	  (Chickering	  et	  al.,	  2012).	  To	  receive	   funding	   from	  the	  private	  sector,	  NABCOA	  aims	  to	  convey	  to	  companies	  that	   wellness	   programs	   are	   a	   worthwhile	   investment.	   NABCOA	   (2012)	   has	   begun	   to	  undergo	  changes	  to	  increase	  investment	  from	  the	  private	  sector.	  Changing	  the	  focus	  of	  its	  programs	  to	  wellness	  as	  a	  whole	  and	  revising	  its	  business	  strategies	  to	  adapt	  to	  Namibia’s	  new	   financial	   situation	   should	   have	   a	   positive	   impact	   on	   NABCOA’s	   effort	   to	   increase	  company	  membership.	  
NABOCA	  recently	  changed	  the	   focus	  of	   its	  programs	   from	  targeting	  only	  HIV/AIDS	  to	   the	  general	   health	   and	   wellness	   of	   employees	   (Chickering	   et	   al.,	   2012).	   General	   wellness	   of	  employees	  encompasses	  HIV/AIDS	  as	  well	  as	  other	  prevalent	  health	  issues	  that	  affect	  the	  Namibian	   workplace.	   The	   negative	   stigma	   that	   is	   often	   associated	   with	   HIV/AIDS	   in	  Namibia	  caused	  employers	  to	  be	  hesitant	  to	  invest	  solely	  in	  HIV/AIDS	  programs.	  Therefore,	  there	   is	   a	   better	   chance	   that	   companies	   will	   invest	   in	   health	   programs	   if	   they	   focus	   on	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overall	  wellness.	  NABCOA	  hopes	  that	  there	  will	  be	  more	  investment	  from	  the	  private	  sector	  in	  these	  broader	  wellness	  programs.	  
Another	  way	  that	  NABCOA	  (2012)	  can	  increase	  support	  from	  the	  private	  sector	  is	  to	  attract	  more	   companies	   to	   become	   members.	   An	   increase	   in	   membership	   means	   that	   more	  companies	   will	   invest	   in	   workplace	   wellness	   programs	   offered	   by	   NABCOA,	   generating	  more	   fees	   while	   making	   healthcare	   services	   more	   accessible	   to	   employees	   throughout	  Namibia.	  NABCOA	  will	  need	  to	  reach	  out	  to	  companies	  that	  have	  a	  high	  potential	  to	  benefit	  from	   workplace	   programs	   but	   have	   not	   already	   done	   so.	   To	   do	   this,	   NABCOA	   plans	   to	  improve	  its	  service	  quality	  and	  reliability.	  NABCOA	  has	  already	  begun	  to	  improve	  upon	  its	  offered	  services	  in	  order	  to	  satisfy	  current	  member	  companies	  and	  attract	  new	  members.	  
2.4.1	  NABCOA’s	  Return	  on	  Investment	  Toolkit	  and	  Cost-­‐Benefit	  Projection	  Model	  One	  way	   that	  NABCOA	  (2012)	  may	  attract	  new	  members	  while	  keeping	  current	  member	  companies	   interested	   in	   available	   health	   services	   is	   to	   show	   the	   financial	   advantages	   of	  workplace	  wellness	  programs.	  NABCOA	  believes	  this	  can	  be	  achieved	  through	  a	  Return	  on	  Investment	   Toolkit,	   which	   consists	   of	   a	   wellness	   advocacy	   toolkit	   and	   a	   cost-­‐benefit	  projection	  model.	  However,	  before	  the	  toolkit	  can	  be	  used,	  the	  projection	  model	  needs	  to	  be	  developed	  and	  piloted.	  While	   the	  development	  of	   the	  model	  will	   take	   time	  due	   to	   the	  need	   to	   collect	   data	   and	   to	   consult	  with	  member	   companies	   to	   understand	   their	   current	  views	  on	  wellness,	  a	  cost-­‐benefit	  projection	  model	  has	  the	  potential	  to	  benefit	  NABCOA	  by	  increasing	  the	  number	  of	  companies	  interested	  in	  investing	  in	  wellness	  programs.	  
In	   particular,	   the	   cost-­‐benefit	   projection	   model	   will	   enable	   private	   sector	   companies	   to	  make	   informed	   decisions	   about	   investing	   in	   wellness	   programs.	   The	   mathematical	   tool	  
18	  	  
illustrates	   the	   financial	  benefits	  of	   investing	   in	  wellness	  programs,	  one	  example	  being	  an	  increase	   in	  employee	  productivity.	  The	  country	  specific	  tool	   identifies	  the	  most	  prevalent	  health	   issues	  with	   an	   epidemiological	   profile	   and	   shows	   how	   interventions	   can	   be	   used	  cost-­‐effectively	   to	   combat	   these	   issues.	   From	   this	   information,	   businesses	   may	   input	  company-­‐specific	   data	   to	   project	   the	   initial	   costs	   of	   the	   wellness	   programs	   and	   the	  expected	  financial	  return	  that	  follows	  from	  the	  investment.	  	  
The	   cost-­‐benefit	   projection	   model	   is	   being	   introduced	   in	   different	   countries	   as	   it	   is	  developed.	  Recently,	  GIZ	  and	  the	  National	  AIDS	  Council	  developed	  a	  cost-­‐benefit	  projection	  model	   for	  employee	  wellbeing	  programs	   for	   the	  private	  sector	  of	  Kenya.	   	  The	  model	  was	  piloted	  from	  October	  2012	  until	  February	  2013	  to	  evaluate	  its	  functionality.	  	  It	  was	  piloted	  at	  Kenya	  Airways,	   the	  Ministry	   of	   Public	  Health	   and	   Sanitation	   (MoPHS),	   the	  Ministry	   of	  Medical	  Services	  (MoMS),	  and	  Thika	  Municipal	  Council	  in	  Kenya.	  Once	  the	  tool	  was	  used	  in	  practice	   it	   was	   well	   received	   and	   has	   proven	   to	   be	   successful	   in	   providing	   private	  companies	  with	  valuable	  evidence	  of	  the	  financial	  benefits	  of	  employee	  healthcare.	  The	  tool	  has	  the	  capability	  of	  promoting	  employee	  healthcare	  to	  the	  private	  sector	  in	  countries	  that	  lack	  access	  to	  such	  healthcare.	  The	  cost-­‐benefit	  projection	  model	  is	  a	  milestone	  in	  achieving	  global	  healthcare	  as	  additional	  countries,	  such	  as	  Namibia,	  begin	  developing	  their	  own.	  	  	  	  	  




Chapter	  3:	  Methodology	  The	   goal	   of	   this	   project	   was	   to	   help	   NABCOA	   with	   the	   development	   of	   a	   cost-­‐benefit	  projection	  model,	  which,	   through	  a	  series	  of	  algorithms,	   identifies	   the	   long-­‐term	  financial	  benefits	   of	   a	   company	   of	   providing	   employees	   with	   healthcare.	   The	   purpose	   of	   the	  projection	   model	   is	   to	   convey	   to	   companies	   the	   economic	   benefits	   of	   investing	   in	  workplace	  wellness	  programs.	  To	  achieve	  our	  goal	  we	   identified	  two	  objectives.	  The	   first	  was	   to	   create	   an	   epidemiological	   profile	   identifying	   the	   largest	   health	   issues	   that	   affect	  Namibia’s	   working	   age	   population.	   The	   second	  was	   to	   develop	   a	   standard	   list	   of	   health	  interventions	   that	   companies	   can	   implement	   in	   their	  workplaces.	   After	  we	   collected	   this	  information,	  we	  populated	  and	   finalized	  the	  model	  by	  using	  this	  data.	   In	   this	  chapter,	  we	  discuss	  in	  greater	  detail	  how	  we	  achieved	  our	  objectives	  and	  our	  goal.	  	  
3.1	  The	  Epidemiological	  Profile	  One	  of	  the	  most	  important	  components	  of	  the	  cost-­‐benefit	  projection	  model	  is	  an	  accurate	  epidemiological	   profile	   of	   the	   target	   population.	   This	   ensures	   that	   when	   Namibian	  companies	  input	  their	  company-­‐specific	  data	  into	  the	  model,	  which	  includes	  the	  number	  of	  males	   and	   female	   employees,	   the	   total	   annual	   salary	   cost,	   total	   annual	   healthcare	   costs,	  number	  of	  working	  days	  per	  year,	  the	  model	  will	  clearly	  illustrate	  how	  the	  most	  prevalent	  health	  problems	  affect	  employees	  and	  company	  profitability.	  We	  completed	  this	  profile	  by	  conducting	   research	   on	   the	   most	   prevalent	   health	   issues	   that	   affect	   the	   Namibian	  workplace.	   In	   order	   to	   provide	   accurate	   information,	   we	   divided	   our	   epidemiological	  profile	  into	  three	  main	  categories:	  morbidity,	  mortality,	  and	  risk	  factors.	  We	  identified	  the	  top	  causes	  of	  employee	  morbidity,	  referring	  to	  sickness,	  and	  the	  top	  causes	  for	  mortality,	  referring	  to	  death.	  Additionally,	  we	  identified	  the	  top	  risk	  factors	  that	  lead	  to	  presenteeism	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in	   the	   workplace.	   These	   factors	   were	   defined	   as	   general	   health	   issues	   that	   may	   lead	   to	  illness	  or	  injury.	  For	  example,	  high	  blood	  sugar	  and	  physical	  inactivity	  can	  ultimately	  lead	  to	  the	  development	  of	  diabetes	  or	  other	  chronic	  health	  problems.	  	  








Table	  3.1:	  Sources	  for	  Epidemiological	  Data	  Collection	  
Organization	   Positions	  
Interviewed	  
Information	  Gathered	   Source	  of	  Data	  






Chief	  Program	  Administrator	  Chief	  Director	  of	  DSP	  
HIV/AIDS,	  Malaria,	  Tuberculosis	   Government	  Documents	  




Deputy	  Director	  of	  Epidemiology	  Division	   Communicable/Non-­‐communicable	  diseases	   Government	  Reports	  
PharmAccess	   Operations	  Manager	  of	  Programs	   Morbidity	  causes,	  risk	  factors	   Wellness	  screening	  Results	  	  
In	  addition,	  we	  reviewed	  documents	  including	  World	  Health	  Organization	  (WHO)	  regional	  health	  reports,	  which	  provided	  us	  with	  an	  initial	  list	  of	  morbidity	  causes	  for	  the	  year	  2008,	  as	  well	  as	  Ministry	  of	  Health	  and	  Social	  Service	  health	  reports,	  such	  as	  Demographic	  Health	  Surveys,	  which	  report	  health	  problems	  for	  the	  entire	  population.	  	  
We	   learned	   that	   it	   can	   be	   difficult	   to	   obtain	   health	   data	   in	   Namibia.	   The	   challenge	   was	  especially	  evident	  when	  working	  with	  the	  morbidity	  section	  of	  the	  epidemiological	  profile.	  Incidence	   rates	   of	   various	   diseases	   were	   harder	   to	   find	   through	   independent	   research	  because	  the	  rates	  require	  data	  on	  the	  number	  of	  reported	  cases	  of	  a	  specific	  health	  problem	  per	  year,	  which	  is	  not	  a	  commonly	  available	  figure.	  We	  had	  to	  request	  morbidity	  data	  from	  sources	   like	   the	   Ministry	   of	   Health	   and	   Social	   Services	   (MoHSS)	   several	   times	   before	  receiving	   usable	   data.	   Getting	   the	   data	   from	   the	   MoHSS	   took	   several	   weeks,	   due	   to	   the	  logistics	  of	  formally	  requesting	  the	  release	  of	  this	  information.	  Once	  this	  data	  was	  obtained,	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we	  were	  able	  to	  determine	  causes	  of	  morbidity,	  as	  well	  as	  update	  our	  mortality	  causes	  from	  the	  2008	  WHO	  data.	  
Calculations	  As	  we	  made	  calculations	  for	  the	  epidemiological	  profile,	  we	  were	  in	  close	  contact	  with	  Dr.	  Patrick	  Hanlon,	  a	  consultant	  from	  the	  Swiss	  Tropical	  and	  Public	  Health	  Institute	  (STI),	  who	  has	   worked	   closely	   with	   NABCOA	   to	   develop	   their	   cost-­‐benefit	   projection	   model.	   Dr.	  Hanlon	   previously	   developed	   a	   cost-­‐benefit	   projection	  model	   for	   Ghana’s	   private	   sector,	  which	  we	  used	  as	  a	  reference	  for	  our	  Namibia-­‐specific	  projection	  model.	  He	  also	  aided	  our	  team	  in	  identifying	  the	  most	  relevant	  epidemiological	  information	  to	  use	  for	  the	  Namibian	  projection	  model.	  	  	  
Once	  the	  data	  had	  been	  collected,	  we	  identified	  the	  most	  prevalent	  health	  issues	  and	  used	  specific	  equations	  to	  calculate	   their	   incidence	  and	  prevalence	  rates.	  The	  generic	  equation	  used	  was	  as	  follows:	  
!"#$   =   !"#$%&  !"  !"#$#!"#$%&'(")   ×  1000	  
To	  specifically	  target	  the	  working	  age	  population	  we	  limited	  our	  data	  to	  include	  only	  health	  issues	  that	  affect	  the	  population	  aged	  18-­‐59.	  To	  find	  the	  appropriate	  population	  figures	  we	  referred	  to	  the	  Namibian	  Housing	  and	  Population	  Census	  from	  2011	  as	  well	  as	  the	  Labor	  Force	   Survey	   from	   2012.	   To	   allow	   for	   gender	   specific	   incidence	   and	   prevalence	   rate	  calculations,	   we	   found	   the	   populations	   for	   women	   18-­‐59	   as	   well	   as	   for	   men	   18-­‐59.	  Incidence	   and	   prevalence	   are	   two	   slightly	   different	   measurements.	   To	   clarify	   the	  difference,	   incidence	  rates	  measure	  the	  number	  of	  new	  cases	  of	  a	  disease	   in	  a	  given	  time	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period,	  often	  within	  a	  year,	  while	  prevalence	  rates	  measure	  the	  total	  number	  of	  cases	  of	  a	  disease	   within	   a	   population	   at	   a	   given	   time	   period.	   Typically,	   prevalence	   is	   used	   as	   a	  measurement	  when	  referring	  to	  illnesses	  that	  are	  chronic	  or	  long-­‐term.	  We	  determined	  the	  incidence	  rates	  of	  the	  top	  twenty	  causes	  of	  morbidity	  and	  top	  ten	  causes	  of	  mortality,	  along	  with	   the	   prevalence	   rates	   of	   the	   top	   ten	   risk	   factors.	   These	   rates	  were	   determined	   on	   a	  national	  scale.	  
Additional	   values	   we	   needed	   to	   complete	   the	   projection	   model	   included:	  inpatient/outpatient	  ratios	  and	  the	  average	  length	  of	  hospital	  stay	  for	  the	  morbidity	  causes,	  and	  the	  annual	  unproductive	  days	  for	  the	  risk	  factors.	  The	  inpatient/outpatient	  ratios	  are	  included	  in	  the	  model	  because	  they	  are	  used	  to	  determine	  absenteeism	  and	  workdays	  lost.	  An	   inpatient	   morbidity	   cause	   refers	   to	   an	   illness	   where	   one	   would	   need	   to	   stay	   in	   the	  hospital	   and	   receive	   treatment	   for	   an	   extended	   period	   of	   time.	   An	   outpatient	  morbidity	  cause	   refers	   to	   an	   illness	  where	  one	  would	   go	   to	   the	  hospital	   for	  diagnosis	   or	   treatment	  without	   needing	   to	   stay	   overnight.	   The	   ratio	   was	   calculated	   for	   each	   morbidity	   health	  problem	  using	  the	  following	  equation:	  
!"#$% =   !"#$%&  !"  !"#$%!&"%  !"#$#!"#$%  !"#$%&  !"  !"#$# 	  
For	   some	  health	  problems,	   the	  number	  of	   inpatient	   cases	  may	  be	  much	  greater	   than	   the	  outpatient	   cases	   and	   vice	   versa.	   The	   ratio	   represents	   this	   difference	   and	   makes	   the	  projected	   workdays	   lost	   a	   more	   accurate	   figure.	   To	   calculate	   the	   ratio,	   we	   had	   to	   pair	  inpatient	  and	  outpatient	  morbidity	  causes	   from	  the	  data	  we	  collected.	  We	  had	   to	  make	  a	  few	   assumptions	   because	   not	   all	   of	   the	   inpatient	   causes	   corresponded	   directly	   with	   the	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outpatient	  causes.	  The	  diagnoses	  used	  when	  reporting	  the	  data	  were	  not	  consistent	  and	  so	  we	   grouped	   together	   inpatient	   and	   outpatient	   causes	   that	   were	   similar,	   enabling	   us	   to	  calculate	  the	  ratios	  for	  eight	  of	  the	  top	  morbidity	  causes.	  
Using	   these	   same	  pairings,	   as	  well	   as	   some	   rough	   estimates,	  we	  determined	   the	   average	  length	   of	   hospital	   stays	   for	   the	   morbidity	   causes.	   We	   obtained	   the	   average	   length	   of	  hospital	   stays	   for	   the	   inpatient	   causes	   from	   the	  MoHSS,	   so	  we	   used	   these	   values	   for	   the	  health	   issues	   that	   were	   paired.	   For	   the	   remaining	   morbidity	   causes,	   we	   referred	   to	   the	  figures	  used	  in	  the	  cost-­‐benefit	  projection	  model	  from	  Ghana.	  We	  assumed	  similar	  hospital	  stay	  figures	  for	  the	  health	  issues	  that	  corresponded	  with	  Ghana’s	  profile,	  and	  then	  for	  the	  remaining	  we	  worked	  with	  Dr.	  Hanlon	  to	  develop	  rough	  estimates.	  
Annual	   unproductive	   days	   represent	   the	   approximate	   amount	   of	   time	   an	   employee	   is	  unproductive	  at	  work	  due	  to	  risk	  factor	  symptoms.	  This	  figure	  is	  important	  for	  the	  model	  to	  calculate	  presenteeism,	  which	  reflects	  the	  number	  of	  employees	  who	  continue	  to	  attend	  work	  when	  ill.	  To	  determine	  these	  figures,	  we	  referenced	  the	  Ghana	  model	  for	  risk	  factors	  that	  corresponded	  and	  then	  developed	  rough	  estimates	  for	  the	  remaining	  factors.	  
3.2	  Determining	  the	  Standard	  Interventions	  After	   collecting	   the	   epidemiological	   data,	  we	   focused	  on	   identifying	  how	  standard	  health	  interventions	   can	   be	   applied	   in	   the	   cost-­‐benefit	   projection	   model.	   The	   standard	  interventions	   are	   the	   health	   services	   that	   companies	   may	   offer	   to	   their	   employees.	   The	  concept	  of	  standard	   intervention	   implies	  that	  certain	   interventions	  can	  be	  developed	  and	  easily	  implemented	  in	  the	  workplace	  of	  many	  companies.	  The	  standard	  interventions	  will	  have	   one	   basic	   cost	   per	   employee	   that	   is	   calculated	   based	   on	   an	   average	   from	  multiple	  
25	  	  
sources	  so	  that	   it	   is	  applicable	  to	  companies	  on	  a	  wide	  scale.	  Using	  the	  model,	  employers	  may	   select	   the	   interventions	   that	   they	  wish	   to	   evaluate,	   and	   the	  model	  will	   calculate	   the	  expected	   economic	   benefits	   based	   on	   the	   cost	   of	   the	   intervention	   and	   company	   specific	  data.	   Specifically,	   the	   model	   identifies	   the	   net	   benefit	   and	   cost-­‐benefit	   ratio	   of	   each	  intervention,	  projecting	  how	  much	  the	  company	  saves	  financially.	  	  	  
To	  decide	  which	   interventions	  should	  be	   included	   in	   the	  model,	  we	  determined	  the	  most	  costly	  health	  problems	  from	  the	  epidemiological	  profile,	  conducted	  research	  on	  workplace	  interventions,	   investigated	   current	   NABCOA	  wellness	   services,	   and	   held	   interviews	  with	  two	  Namibian	  companies.	  We	  compiled	  a	  list	  of	  health	  problems	  that	  should	  be	  addressed	  with	   interventions	   in	   the	  model	  based	  on	  which	  health	  problems	  the	  model	  calculated	  to	  have	   the	  highest	   costs.	  To	  develop	  a	  better	  understanding	  of	   the	   interventions	   that	   exist	  currently,	  we	  referred	  to	  the	  World	  Health	  Organization’s	  CHOICE	  (CHOosing	  Interventions	  that	  are	  Cost	  Effective)	  project,	  which	  lists	  the	  costs	  of	  interventions	  used	  in	  the	  southern	  African	   region,	   the	   estimated	   cost-­‐effectiveness	   of	   each	   intervention,	   and	   the	   Disability	  Adjusted	  Life	  Years	  (DALYs)1	  averted.	  We	  compared	  the	  WHO-­‐CHOICE	  interventions	  to	  our	  list	   of	   prominent	   health	   concerns	   and	   selected	   the	   interventions	   that	   would	   be	   most	  appropriate	  for	  inclusion	  in	  the	  model.	  
Additionally,	   we	   focused	   on	   creating	   a	   package	   of	   interventions	   that	   targeted	   general	  wellness.	  Since	  many	  of	  NABCOA’s	  programs	  are	  aimed	  at	  promoting	  wellness,	  we	  worked	  with	   representatives	   from	  NABCOA	   to	   determine	  which	  wellness	   services	   and	   programs	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	  As	  stated	  on	  the	  WHO	  (2013)	  website,	  DALYs	  are	  a	  “time-­‐based	  measure	  that	  combines	  years	  of	  life	  lost	  due	  to	  premature	  mortality	  and	  years	  of	  life	  lost	  due	  to	  time	  lived	  in	  states	  of	  less	  than	  full	  health”	  (para.	  3).	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are	  most	  often	  offered	   to	   the	  private	   sector.	  Through	   informal	  discussions	  with	  wellness	  coordinator	   staff	   members	   at	   NABCOA,	   we	   gathered	   the	   costs	   associated	   with	   some	   of	  these	  programs.	  Another	  source	  of	  information	  recommended	  by	  NABCOA	  was	  Walvis	  Bay	  Corridor	  Group	   (WBCG).	  WBCG	  offers	  health	   and	  wellness	  programs	   similar	   to	  NABCOA,	  but	   specifically	   for	   the	   transport	   sector.	   We	   met	   informally	   with	   the	   Wellness	   Service	  Program	  Manager	  to	  see	  if	  we	  could	  obtain	  the	  costs	  of	  their	  programs	  so	  that	  we	  would	  be	  able	  to	  calculate	  averages	  when	  developing	  the	  costs	  of	  our	  standard	  interventions.	  
We	  also	   interviewed	   two	  companies,	  Olthaver	  &	  List	  and	  De	  Beers	  Group,	   to	   identify	   the	  programs	  they	  offer	  and	  to	  compare	  the	  programs	  and	  costs	  with	  those	  listed	  on	  the	  WHO-­‐CHOICE	   project	   website.	   We	   looked	   for	   any	   overlap	   between	   the	   programs	   that	   these	  companies	  have	  implemented	  in	  the	  workplace	  and	  the	  interventions	  we	  selected	  from	  the	  WHO-­‐CHOICE	  website.	  We	  defined	   the	  presence	  of	  an	  overlap	   to	  be	  an	   indicator	   that	   the	  intervention	   would	   be	   a	   suitable	   addition	   to	   our	   list	   of	   standard	   interventions,	   as	   the	  overlap	  suggests	  that	  the	  intervention	  may	  be	  used	  by	  a	  number	  of	  companies	  already.	  The	  standard	  interventions	  are	  meant	  to	  be	  feasible	  for	  most	  companies,	  so	  in	  identifying	  which	  interventions	   are	   already	   commonly	   used	  we	  were	   able	   to	   consider	   how	   to	   best	  modify	  their	  wellness	  service	  components	  and	  costs	  so	  that	  they	  can	  be	  standardized.	  
For	   interventions	   to	  be	  entered	   into	   the	  model	  and	   the	  net	  benefit	  and	  cost-­‐benefit	   ratio	  calculated,	   there	   are	   specific	   values	   that	  must	   be	   determined.	   These	   values	   include:	   the	  duration	  of	  the	  intervention	  in	  years,	  the	  percentage	  of	  employee	  coverage,	  the	  annual	  cost	  per	   employee,	   and	   the	   resulting	   percent	   reduction	   in	   morbidity	   and	   mortality.	   In	   our	  interviews	  and	  informal	  meetings	  we	  included	  questions	  to	  determine	  these	  values	  for	  our	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wellness	   package	   interventions,	   but	  we	   had	   difficulty	   getting	   answers	   for	   each	   value.	   In	  addition	   to	   the	   interviews,	  we	   searched	   for	   studies	   conducted	  on	  health	   interventions	   in	  developing	   countries	   to	   help	   identify	   the	   reduction	   in	   morbidity	   and	   mortality	   rates	   of	  these	  interventions.	  The	  reduction	  rates	  are	  an	  important	  part	  of	  the	  model	  because	  they	  illustrate	  the	  cost-­‐effectiveness	  of	  the	  interventions	  and	  their	  direct	  impact	  on	  health	  in	  the	  workplace.	  Most	  companies	  cannot	  easily	  calculate	  these	  reductions	  because	  they	  involve	  extensive	  monitoring	  over	  a	  long	  period	  of	  time.	  	  
3.3	  Populating	  the	  Model	  After	   collecting	   epidemiological	   data	   and	   identifying	   the	   standard	   interventions,	   we	  entered	   our	   findings	   into	   the	   cost-­‐benefit	   projection	   model,	   which	   was	   formatted	   in	  Microsoft	  Excel	  by	  Dr.	  Hanlon	  using	  a	  structure	  similar	  to	  the	  Ghanaian	  model.	  The	  model	  was	  organized	  into	  several	  different	  sections	  as	  seen	  in	  Figure	  3.1	  We	  worked	  closely	  with	  Dr.	   Hanlon	   to	   enter	   data	   in	   both	   the	   magenta-­‐colored	   tab	   categories,	   containing	   the	  epidemiological	  profile,	  and	  the	  orange-­‐colored	  tab	  categories,	  containing	  the	  intervention	  information.	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Figure	  3.1:	  An	  overview	  of	  the	  cost-­‐benefit	  projection	  model’s	  organization	  	  We	  shared	  our	  collected	  epidemiological	  data	  with	  Dr.	  Hanlon	   through	  email.	  Dr.	  Hanlon	  then	   reviewed	  our	  data	   and	   advised	  us	   regarding	  which	  data	  would	  be	  most	   relevant	   to	  use.	  We	  entered	  prevalence	  rates	  for	  the	  risk	  factors	  as	  percentages	  and	  the	  incidence	  rates	  for	  mortality	  and	  morbidity	  per	  1000	  people,	  as	  advised	  by	  Dr.	  Hanlon.	  This	  way,	  the	  data	  were	  in	  the	  correct	  format	  needed	  for	  the	  algorithm	  calculations	  used	  in	  Microsoft	  Excel.	  	  
We	  worked	  to	  further	  develop	  interventions	  that	  suited	  the	  concept	  of	  standardization,	  but	  faced	  the	  challenge	  of	  missing	  data	  values.	  Our	  interventions	  were	  not	  added	  to	  the	  model,	  but	  are	  discussed	  in	  the	  next	  chapter	  as	  examples	  of	  how	  an	  intervention	  could	  be	  applied	  to	   the	  model.	   The	  model	   does	  not	   need	   interventions	   to	   calculate	   the	  most	   costly	   health	  problems,	  but	  instead	  allows	  for	  companies	  to	  evaluate	  if	  they	  can	  cost-­‐effectively	  reduce	  certain	   issues	   that	  are	  prevalent	   in	   the	  workplace.	  The	  model	  calculates	  how	  much	  of	  an	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impact	  an	   intervention	  would	  have	  on	   their	  workforce	  based	  on	   the	   intervention’s	   initial	  costs	   and	   costs	   per	   employee.	   Companies	   can	   add	   interventions	   to	   the	   model	   to	   target	  specific	  health	  issues	  as	  needed.	  
On	  April	  22nd,	  Dr.	  Hanlon	  arrived	  in	  Namibia	  from	  Switzerland	  to	  examine	  and	  help	  finalize	  the	   cost-­‐benefit	   projection	   model.	   On	   the	   22nd	   and	   the	   23rd,	   we	   presented	   our	  epidemiological	  profile	  and	  interventions	  at	  workshops	  to	  get	  feedback	  before	  Dr.	  Hanlon	  held	  training	  sessions	  during	  the	  latter	  half	  of	  the	  week.	  These	  workshops	  provided	  a	  first	  look	  at	   the	  model	   for	  about	   twenty	  wellness	  managers	   from	  organizations	   including	  GIZ,	  NABCOA,	   The	   Center	   for	   Disease	   Control	   (CDC),	   the	   Standard	   Bank,	   Bank	   Windhoek,	  UNAIDS,	  De	  Beers	  Group,	  Olthaver	  &	  List,	  PharmAccess,	  and	  the	  MoHSS.	  After	  presenting	  the	   data	   we	   had	   collected	   for	   the	   model,	   we	   were	   able	   to	   get	   feedback	   from	   these	  representatives	   on	   any	   concerns	   or	   reactions	   they	  had	   about	   the	  model.	  Dr.	  Hanlon	   also	  provided	   insights	   on	   how	   the	  model	   could	   be	   improved	   before	   the	   training	   session,	   and	  based	   on	   his	   recommendations	  we	  made	   changes	   to	   the	  model	   in	   the	   areas	   that	   needed	  strengthening.	   	  One	  of	   the	  major	  areas	   that	  was	  addressed	   in	   the	  workshop	  pertained	   to	  risk	  factors.	  We	  presented	  two	  sources	  of	  risk	  factor	  data,	  from	  the	  WHO	  and	  PharmAccess,	  and	  asked	   for	   input	  on	  which	   set	  would	   represent	   the	  working	  population	  best.	  We	  also	  discussed	  using	  prevalence	  rates	  in	  place	  of	  incidence	  rates	  for	  chronic	  conditions	  such	  as	  HIV.	   For	  HIV,	   the	   incidence	   rate	   only	  measures	   how	  many	   people	  were	   reported	   to	   test	  positive	  in	  a	  year,	  not	  the	  total	  population	  affected	  by	  the	  health	  problem.	  
After	  finalizing	  the	  model,	  Dr.	  Hanlon	  and	  GIZ	  facilitated	  a	  training	  session	  from	  April	  24nd	  to	   the	   26th	   for	   members	   of	   GIZ,	   NABCOA,	   PharmAccess,	   WBCG,	   and	   private	   sector	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representatives	   from	   the	  Standard	  Bank,	  Bank	  Windhoek,	  and	  Olthaver	  &	  List	  on	  how	   to	  use	  the	  model.	  Our	  team	  attended	  these	  training	  sessions	  to	  evaluate	  whether	  the	  tool	  was	  user-­‐friendly	  and	  understandable	  based	  on	  how	  easily	   individuals	  understood	  the	  model.	  Comments	   and	   suggestions	   were	   noted	   by	   the	   team	   and	   considered	   when	  making	   final	  recommendations	   for	   the	   projection	  model’s	   future	   success.	   After	   attending	   the	   training	  sessions,	  we	  were	  able	  to	  make	  final	  recommendations	  to	  NABCOA	  on	  how	  to	  prepare	  for	  the	  piloting	  of	  the	  cost-­‐benefit	  projection	  model.	  	  
In	  the	  next	  chapter	  of	  this	  report,	  we	  will	  discuss	  our	  findings	  on	  the	  epidemiological	  data	  and	  interventions.	  We	  will	  identify	  the	  top	  causes	  of	  morbidity,	  top	  causes	  of	  mortality,	  and	  top	   risk	   factors	   for	   the	   working	   age	   population	   in	   Namibia.	   We	   will	   also	   explain	   the	  possible	  and	  most	  likely	  healthcare	  interventions	  in	  detail.	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Chapter	  4:	  Results	  &	  Analysis	  In	   this	   chapter,	   we	  will	   discuss	   the	   epidemiological	   data	   that	  we	   collected	   on	   Namibia’s	  working	   age	   population	   and	   our	   findings	   on	   how	   healthcare	   interventions	   should	   be	  included	  in	  the	  cost-­‐benefit	  projection	  model	  being	  developed	  by	  NABCOA	  and	  GIZ.	  Using	  the	  data	  we	  obtained	  from	  various	  sources,	  we	  were	  able	  to	  complete	  an	  epidemiological	  profile,	   determine	  Namibia’s	   top	   causes	   of	  morbidity,	  mortality,	   and	  other	  health-­‐related	  risk	  factors,	  and	  identify	  how	  several	  interventions	  can	  help	  employee	  health	  and	  wellness.	  
4.1:	  Epidemiological	  Profile:	  Mortality,	  Morbidity,	  and	  Risk	  Factors	  To	  present	  the	  results	  for	  the	  epidemiological	  profile,	  we	  will	  breakdown	  each	  component	  by	  first	  giving	  the	  results	  for	  mortality,	  then	  morbidity,	  and	  then	  risk	  factors.	  




Figure	  4.1:	  Namibia’s	  Top	  Mortality	  Rates	  for	  Males	  and	  Females	  
There	   were	   significant	   differences	   between	   males	   and	   females	   for	   a	   number	   of	   the	  mortality	   causes.	   The	   data	   show	   that	   HIV/AIDS	   is	   the	   number	   one	   cause	   of	   death	   for	  women,	  but	  that	  tuberculosis	  is	  the	  number	  one	  cause	  of	  death	  for	  men.	  Many	  data	  reports	  have	   suggested	   that	   HIV	   infection	   rates	   are	   higher	   among	   women	   than	   men.	   In	   an	  Estimates	  and	  Projections	  Report	  from	  the	  MoHSS	  (2012),	  we	  found	  that	  67%	  of	  new	  HIV	  infections	  in	  the	  15-­‐24	  age	  population	  are	  young	  women	  (p.	  19).	  The	  MoHSS	  also	  reports	  in	  their	   Demographic	   and	   Health	   Survey	   (2006)	   that	   on	   average,	   the	   number	   of	   sexual	  partners	  reported	  by	  men	  is	  seven,	  while	  the	  number	  reported	  by	  women	  is	  two	  (p.	  207).	  It	  is	  possible	  that	  these	  numbers	  could	  have	  been	  falsely	  reported	  in	  an	  attempt	  for	  men	  to	  seem	  manlier	   and	  women	  more	  matronly.	   In	   some	  Namibian	   tribes,	  men	   are	   allowed	   to	  have	   numerous	   wives	   and	   sexual	   partners,	   and	   in	   many	   cultures	   the	   male	   acts	   as	   the	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dominant	  household	  figure	  (Brown,	  Sorrell,	  &	  Raffaelli,	  2005).	  These	  statistics	  and	  cultural	  beliefs	  could	  lead	  to	  women	  being	  put	  at	  a	  higher	  risk	  of	  contracting	  HIV	  from	  a	  male	  with	  riskier	   sexual	   practices,	   potentially	   causing	   HIV	   to	   be	   a	   greater	   cause	   of	   mortality	   for	  women	  than	  men.	  The	  data	  we	  obtained	  from	  the	  MoHSS	  supports	  this	  conclusion,	  but	  it	  is	  possible	  that	   there	   is	  data	  missing	   from	  the	  MoHSS	  reports,	  or	   that	  some	  people	   infected	  with	  HIV	  are	  not	  seeking	  care	  from	  medical	  facilities	  and	  are	  thus	  underreported.	  For	  HIV	  to	  be	  accurately	  reported,	  individuals	  must	  be	  willing	  to	  be	  tested.	  However,	  it	  is	  possible	  that	   many	   refrain	   from	   being	   tested	   because	   of	   the	   stigma	   against	   HIV.	   In	   the	   case	   of	  reporting	  a	  death	  caused	  by	  AIDS,	  family	  members	  may	  sometimes	  say	  that	  another	  health	  problem	  was	  the	  cause	  of	  death	  to	  avoid	  being	  stigmatized	  by	  having	  a	  family	  member	  that	  died	  from	  HIV/AIDS.	  	  
Another	   difference	   is	   that	   tuberculosis	   is	   a	   much	   higher	   cause	   of	   death	   for	   men	   than	  women,	  a	  trend	  that	   is	  supported	  by	  the	  WHO	  (2013),	  as	  they	  state	  on	  their	  website	  that	  many	  men	  are	  diagnosed	  with	  and	  killed	  by	  tuberculosis	  (p.	  1).	  Often	  times	  in	  HIV	  positive	  persons,	  it	  is	  common	  to	  contract	  other	  illnesses,	  as	  HIV	  weakens	  the	  immune	  system	  and	  makes	  the	  body	  more	  susceptible	   to	  pathogens.	   	   It	   is	  not	  uncommon	  for	  someone	  who	   is	  HIV	  positive	   to	  also	  become	  infected	  with	  tuberculosis.	  The	  method	  of	  data	  collection	   for	  this	   information	   is	   not	   known,	   so	   it	   is	   possible	   that	   there	   are	   errors.	   Specifically,	   there	  could	  have	  been	  a	  misreporting	  of	  deaths	  caused	  by	  tuberculosis	   in	  HIV	  positive	  persons.	  For	   example,	   in	   a	   person	   infected	   with	   both	   HIV	   and	   tuberculosis,	   tuberculosis	   may	   be	  reported	  as	  the	  primary	  cause	  of	  death	  when	  the	  underlying	  cause	  was	  actually	  AIDS.	  This	  underrepresents	   the	   fatality	   rate	   from	  HIV/AIDS,	   but	   is	   also	   a	   relevant	   consideration	   for	  any	  chronic	  condition	  that	  makes	  the	  body	  more	  susceptible	  to	  illness.	  While	  these	  errors	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are	  speculated,	   they	  quite	   likely	  exist,	  and	  therefore	  should	  be	  considered	   in	   interpreting	  the	  data	  and	  identifying	  the	  necessary	  health	  interventions.	  
Overall,	  the	  main	  takeaway	  from	  the	  mortality	  section	  of	  the	  epidemiological	  profile	  is	  that	  there	  are	  other	  prevalent	  causes	  of	  death	  besides	  the	  widely	  reported	  health	  issues	  such	  as	  HIV/AIDS	  and	  tuberculosis.	  While	  these	  illnesses	  are	  still	  very	  common,	  non-­‐communicable	  diseases	   and	   various	   injuries	   are	   other	   conditions	   that	   should	   be	   considered	   when	  analyzing	  causes	  of	  mortality	  of	  the	  working	  age	  population.	  These	  other	  health	  problems	  accounted	  for	  the	  remaining	  eight	  mortality	  causes.	  	  
Morbidity	  One	  of	  our	  main	  findings	  was	  that	  there	  is	  a	  very	  limited	  amount	  of	  country-­‐specific	  data	  available.	   However,	   we	   determined	   the	   top	   twenty	   morbidity	   causes,	   from	   2012	   data	  provided	  by	  the	  MoHSS,	  as	  listed	  in	  Figure	  4.2.	  The	  calculated	  incidence	  rates	  can	  be	  found	  in	  Appendix	  E	  along	  with	  the	  in/outpatient	  ratios	  and	  average	  length	  of	  hospital	  stay	  data.	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Figure	  4.2:	  Namibia’s	  Top	  Morbidity	  Rates	  for	  Males	  and	  Females	  
The	   number	   one	   cause	   of	  morbidity	  was	  musculoskeletal	   system	   disorders,	   followed	   by	  other	  respiratory	  disease	  diagnoses,	   trauma,	  and	  HIV/AIDS.	  We	  were	  concerned	  with	  the	  broadness	  of	   some	  categories,	   especially	  with	  many	  of	   the	   top	  causes	  of	  morbidity	  being	  categories	  that	  started	  with	  “other”.	  These	  could	  encompass	  a	  variety	  of	  health	  problems,	  which	   is	   of	   little	   use	   to	   the	   cost-­‐benefit	   projection	   model.	   To	   understand	   why,	   we	   will	  explain	   using	   the	   top	   cause	   of	   morbidity	   as	   an	   example.	   The	   top	   cause	   of	   morbidity,	  musculoskeletal	  system	  disorders,	  is	  a	  very	  broad	  category	  of	  health	  problems.	  After	  some	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speculation	  on	  what	  this	  classification	  may	  include,	  we	  consider	  that,	  among	  others,	  issues	  such	  as	  back	  pains	  and	  pulled	  muscles	  may	  be	  included.	  The	  epidemiological	  profile	  needs	  to	  identify	  specific	  health	  problems	  so	  that	  when	  companies	  use	  the	  projection	  model	  they	  can	   identify	   which	   problems	   are	   most	   relevant	   and	   should	   be	   targeted	   with	   an	  intervention.	  During	   discussions	   at	   the	  workshop	   preceding	   the	   training	   sessions	   on	   the	  cost-­‐benefit	   projection	   model,	   we	   decided	   the	   best	   way	   to	   move	   forward	   would	   be	   to	  return	  to	  the	  MoHSS,	  where	  we	  got	  the	  data,	  and	  ask	  for	  clarity	  on	  what	  each	  broad	  health	  category	  includes.	  	  
Based	  on	   feedback	   from	   the	  workshop	  discussion,	  we	   replaced	   the	   incidence	   rate	  with	  a	  prevalence	  rate	  for	  HIV/AIDS.	  Originally	  the	  incidence	  rate	  put	  HIV/AIDS	  as	  the	  last	  of	  the	  top	  morbidity	  issues,	  as	  it	  was	  a	  measure	  of	  how	  many	  people	  were	  tested	  positive	  and	  not	  the	   total	   number	   of	   people	   living	   with	   HIV/AIDS.	   Upon	   replacing	   the	   rate	   to	   represent	  prevalence,	   HIV/AIDS	   became	   ranked	   as	   the	   fourth	   morbidity	   cause,	   which	   is	   a	   more	  realistic	  representation	  of	  the	  disease’s	  presence	  in	  the	  population.	  
While	  the	  data	  obtained	  from	  the	  MoHSS	  provided	  a	  general	  overview	  of	  Namibia’s	  health	  profile,	   there	   were	   some	   additional	   limitations	   to	   the	   data.	   Mainly,	   the	   data	   was	   not	  separated	  by	  gender.	  The	  values	  in	  Figure	  4.2	  were	  calculated	  for	  males	  and	  females	  using	  the	  total	  number	  of	  reported	  cases,	  assuming	  that	  there	  is	  no	  significant	  difference	  in	  how	  these	  health	  problems	  affect	  men	  and	  women.	  We	  had	  to	  then	  assume	  that	  for	  the	  health	  problems	   that	   are	   specific	   to	   females,	   such	   as	   vaginal	   discharge,	   that	   the	   rate	   for	  males	  would	   be	   zero.	   It	   is	   important	   that	   the	   incidence	   rates	   are	   gender-­‐specific	   so	   that	   the	  algorithms	   accurately	   calculate	   how	   health	   problems	   impact	   males	   and	   females.	   These	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values	  provide	  a	  strong	  basis	  of	  the	  top	  morbidity	  causes,	  but	  could	  use	  more	  specificity	  in	  definition	  of	  health	  problems	  as	  well	  as	  in	  incidence	  rates	  for	  males	  and	  females.	  
Risk	  Factors	  We	   identified	   the	   top	   health	   risk	   factors	   for	   the	   working	   age	   population,	   which	   are	  represented	   in	   Figures	   4.3	   and	   4.4	   These	   data	   came	   from	   two	   sources:	   the	   WHO	   and	  PharmAccess.	  We	  refrained	  from	  combining	  the	  risk	  factors	  from	  each	  source	  because	  they	  represent	   two	  different	  populations.	  The	  WHO	  data	   is	  based	  on	  national	  averages	   for	   the	  ages	  corresponding	   to	   the	  working	  age	  population	  18-­‐59,	  whereas	   the	  PharmAccess	  data	  represents	   the	   private,	   rural	   working	   age	   population	   using	   data	   from	   Bophelo!	   mobile	  testing	  units.	  There	  were	  some	  differences	  between	  the	  two	  sources.	  For	  example,	  for	  high	  blood	  pressure,	   the	  WHO	   reported	   that	   51%	  of	  men	   are	   at	   risk	  while	   PharmAccess	  data	  suggested	   that	  only	  8%	  are	  at	   risk.	  The	  difference	   is	   from	  each	  source	  having	  a	  different	  threshold	  for	  “high	  blood	  pressure.”	  The	  WHO	  measures	  raised	  blood	  pressure,	  defined	  as	  a	  systolic	   blood	   pressure	   greater	   than	   140	   mmHg,	   and	   Bophelo!	   measures	   high	   blood	  pressure,	  which	  was	  defined	  as	  a	  systolic	  blood	  pressure	  greater	  than	  155	  mmHg.	  A	  group	  discussion	  at	  the	  workshop	  on	  the	  epidemiological	  profile	  led	  us	  to	  discover	  that	  Bophelo!	  can	   also	   provide	   data	   using	   the	   same	   baseline	   as	   the	   WHO,	   making	   the	   data	   more	  comparable.	   Once	   this	   information	   becomes	   available,	   it	   can	   be	   used	   in	   the	   profile.	   The	  percentages	  for	  each	  of	  the	  other	  risk	  factors	  and	  their	  annual	  unproductive	  day	  values	  can	  be	  found	  in	  Appendix	  F.	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Figure	  4.3:	  WHO	  Risk	  Factors	  for	  Males	  and	  Females	  	  
	  
Figure	  4.4:	  PharmAccess	  Risk	  Factors	  for	  Males	  and	  Females	  	  Another	  difference	  between	  the	  data	  sets	  is	  that	  WHO	  measures	  raised	  blood	  glucose	  while	  PharmAccess	  measures	   hyperglycemia	   (high	   blood	   sugar	   levels)	   and	   hypoglycemia	   (low	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blood	   sugar	   levels).	   These	   risk	   factors	   are	   not	   directly	   comparable,	   since	   the	  WHO	   data	  measures	   a	   raised	   level	   of	   glucose	   while	   the	   PharmAccess	   data	   measures	   high	   and	   low	  levels,	  which	  are	  merged	  into	  one	  abnormal	  glucose	  level	  prevalence	  rate.	  
In	  general,	  it	  is	  important	  to	  consider	  risk	  factors	  in	  the	  cost-­‐benefit	  projection	  model	  when	  evaluating	   people’s	   health	   because	   if	   left	   unaddressed,	   these	   risks	   have	   the	   potential	   to	  develop	   into	  more	   serious	   health	   problems.	   For	   example,	   excessive	   alcohol	   consumption	  has	   been	   linked	   to	   causing	  more	   cases	   of	   risky	   sexual	   practices,	   which	   can	   increase	   the	  chance	   of	   contracting	   HIV	   (Woolf-­‐King,	   et	   al.,	   2013).	   Tobacco,	   as	   another	   example,	   is	  commonly	  known	  to	  lead	  to	  cancers	  of	  the	  lungs,	  mouth,	  lips,	  nasal	  cavity,	  and	  esophagus	  (American	  Cancer	  Society,	  2013).	  
We	  noticed	  several	  trends	  in	  the	  risk	  factor	  data.	  Tobacco	  use	  and	  alcohol	  consumption	  are	  slightly	  more	   prevalent	   in	  men	   than	  women.	  We	   found	   that	   obesity	   is	  more	   common	   in	  women	  than	   in	  men.	  After	  speaking	  with	  some	  of	   the	  NABCOA	  staff,	  we	   learned	  that	   in	  a	  Namibian	   household	   relationship,	   if	   a	   woman	   is	   overweight,	   it	   is	   understood	   that	   her	  husband	  is	  providing	  for	  her	  wellbeing.	  This	  cultural	  belief	  could	  be	  a	  contributing	  factor	  to	  the	  prevalence	  of	  obesity	  in	  women	  in	  the	  working	  age	  population.	  It	  was	  interesting	  to	  see	  that	   the	   WHO	   reported	   the	   top	   risk	   factor	   for	   both	   men	   and	   women	   to	   be	   physical	  inactivity,	   which	   is	   surprising	   as	   one	   of	   the	  main	  methods	   of	   transportation	   among	   the	  working	  class	  is	  walking	  to	  and	  from	  their	  jobs.	  The	  WHO	  data	  defines	  physical	  inactivity	  as	  less	   than	  30	  minutes	  of	  moderate	   exercise	   five	   times	   a	  week,	   or	   less	   than	  20	  minutes	  of	  vigorous	  exercise	  three	  times	  a	  week.	  For	  men	  and	  women	  who	  live	  in	  the	  Khomas	  region	  informal	  settlements	  surrounding	  Katutura,	  the	  walk	  to	  Windhoek’s	  places	  of	  employment	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can	   be	   long	   and,	   in	   some	   situations,	   strenuous.	   This	   type	   of	   exercise	   is	   most	   likely	   not	  considered	  in	  the	  data	  provided	  by	  the	  WHO.	  
At	   the	   workshops	   where	   we	   presented	   our	   data	   among	   wellness	   managers	   and	   other	  health	  representatives,	  the	  final	  consensus	  was	  that	  the	  Bophelo!	  data	  would	  be	  the	  most	  appropriate	   for	   the	   model.	   There	   were	   some	   concerns	   raised	   with	   the	   method	   of	   data	  collection	  used	  by	   the	  WHO	  when	  determining	   the	   risk	   factor	   data,	   as	   it	  was	  derived	  by	  estimation	  based	  on	  modeling	  and	  not	  direct	  data	  collection.	  Many	  of	  those	  who	  attended	  the	  workshop	  preferred	   the	  Bophelo!	  data,	   as	   they	  were	  directly	   collected	  by	   the	  mobile	  testing	  units	  that	  visited	  company	  workplaces.	  The	  data	  from	  Bophelo!	  were	  also	  collected	  in	   a	   year	   when	   the	   participation	   rate	   for	   testing	   was	   about	   90%,	   providing	   a	   good	  representation	   of	   the	  workforce.	   Additionally,	   the	  mobile	   testing	   units	   travelled	   to	   rural	  areas	  in	  almost	  all	  of	  Namibia’s	  regions,	  collecting	  data	  that	  was	  geographically	  diverse.	  For	  these	   reasons,	   the	   Bophelo!	   risk	   factors	   were	   selected	   to	   be	   included	   in	   the	   model.	   To	  incorporate	  as	  many	  risk	  factors	  as	  possible,	  we	  also	  decided	  to	  use	  the	  WHO	  risk	  factors	  that	  were	  not	  measured	  by	  Bophelo!,	  which	   included	  alcohol	   consumption,	  daily	   tobacco	  use,	  physical	   inactivity,	  and	  raised	  cholesterol.	  These	  combined	  risk	   factors	  are	  shown	   in	  Figure	  4.5.	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Figure	  4.5:	  Combined	  Risk	  Factors	  for	  Males	  and	  Females	  
We	   also	   determined	   that	   there	  might	   be	   underreporting	   of	   some	   risk	   factors.	   Regarding	  substance	   abuse,	   the	   values	   can	   be	   difficult	   to	   measure,	   as	   they	   require	   individuals	  disclosing	   information	   that	   they	  may	  not	  want	   to	   share.	   If	   individuals	  under-­‐report	   their	  use	  of	  alcohol	  or	  drug	  use,	  it	  may	  result	  in	  rates	  that	  are	  lower	  than	  the	  true	  values.	  	  
Epidemiological	  Profile:	  Limitations	  and	  Future	  Developments	  We	   assembled	   a	   complete	   epidemiological	   profile	   of	   Namibia’s	   most	   pressing	   health	  concerns	   using	   available	   data,	   but	   there	   were	   several	   limitations	   to	   our	   data	   collection.	  Initially,	  it	  was	  difficult	  to	  find	  recent	  data	  for	  the	  working	  age	  population,	  ideally	  gathered	  within	  the	  last	  three	  years.	  	  We	  also	  had	  a	  limited	  number	  of	  data	  sources.	  The	  only	  three	  places	  we	   located	  health-­‐related	  data	   for	  Namibia	  were	   the	  WHO	  website,	   PharmAccess,	  and	   the	   MoHSS.	   As	   mentioned,	   the	   WHO	   data	   was	   out	   of	   date,	   the	   PharmAccess	   data	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captured	  a	  relatively	  small	  population	  from	  the	  private	  sector,	  while	  the	  MoHSS	  data	  was	  only	  for	  the	  population	  that	  uses	  public	  healthcare	  facilities.	  
The	   information	   collected	   from	   MoHSS	   contained	   cases	   from	   the	   public	   hospitals	   in	  Namibia.	   To	   make	   sure	   that	   we	   used	   the	   most	   accurate	   population	   figures	   in	   our	  calculations,	  we	  had	  to	  calculate	  how	  many	  people	  use	  public	  healthcare	  facilities	  based	  on	  who	  was	  covered	  by	  government	  health	  insurance,	  private	  health	  insurance,	  or	  who	  is	  not	  covered	  at	  all.	  We	  received	  information	  from	  medical	  aid	  saying	  that	  8.5%	  of	  the	  Namibian	  population	   is	   covered	   by	   private	   health	   insurance,	   8.5%	   is	   covered	   by	   public	   health	  insurance,	   and	   83%	   of	   the	   population	   is	   uninsured	   (Mbapaha,	   2011).	   Based	   on	   these	  figures	  and	  estimates	  provided	  by	  the	  MoHSS,	  we	  recognized	  that	  for	  the	  morbidity	  cases	  requiring	  only	  outpatient	  care,	   the	   insured	  population	  visited	  private	  health	   facilities	  and	  therefore	   the	   number	   of	   morbidity	   cases	   used	   in	   the	   model	   accounted	   for	   83%	   of	   the	  population.	  	  For	  the	  mortality	  cases,	  91.5%	  of	  the	  population	  was	  included,	  since	  both	  the	  uninsured	   and	  publicly	   insured	  people	  would	  use	   the	  public	   hospitals	   for	   inpatient	   care,	  while	   the	   privately	   insured	   people	   would	   only	   use	   private	   hospitals.	   Therefore,	   the	  projection	  model	   is	  currently	  missing	  the	  part	  of	   the	  population	  that	   is	  privately	   insured.	  The	  missing	  information	  could	  skew	  our	  data	  by	  elevating	  mortality	  and	  morbidity	  rates,	  as	  the	  population	  who	  can	  afford	  private	  healthcare	  insurance	  most	  likely	  does	  not	  fall	   ill	  as	  severely	  or	  frequently.	  To	  work	  toward	  a	  more	  balanced	  representation	  of	  the	  working	  age	  population	   as	   a	   whole,	   we	   would	   like	   to	   obtain	   data	   on	   the	   privately	   insured.	   Medical	  insurance	  companies	  could	  supply	  these	  data	  based	  on	  claims.	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Overall,	  there	  may	  be	  some	  errors	  in	  the	  data.	  It	  is	  possible	  that	  a	  portion	  of	  the	  population	  does	  not	  visit	  the	  hospital	  when	  they	  are	  sick	  and	  therefore	  is	  not	  represented	  in	  the	  data.	  Also,	  some	  people	  may	  choose	  to	  not	  get	  tested	  for	  certain	  diseases,	  and	  therefore	  they	  may	  contribute	  to	  the	  under-­‐reporting	  of	  cases	  such	  as	  HIV/AIDS.	  	  
Another	   limitation	   involves	   the	   ages	   included	   in	   the	   reported	   cases.	   For	   morbidity	   and	  mortality,	   the	   data	   include	   ages	   18+,	  meaning	   that	   of	   the	   reported	   cases	   for	   each	   health	  problem,	   there	   could	   have	   been	   a	   number	   of	   retired	   persons	   included.	   Ideally,	   the	   cases	  that	  relate	  to	  the	  retired	  population	  would	  not	  be	  included	  in	  the	  model,	  as	  they	  most	  likely	  skew	  the	  data	  by	  elevating	  mortality	  and	  morbidity	  incidence	  rates	  for	  certain	  illnesses	  or	  causes	  of	  death.	  To	  remove	  this	  population	  from	  the	  model,	  we	  would	  need	  to	  obtain	  the	  health	  problems	  by	  age	  group.	  Then	  any	  reported	  cases	  for	  ages	  60+	  could	  be	  disregarded.	  Additionally,	   as	   mentioned	   earlier,	   some	   health	   categories	   in	   these	   sections	   are	   overly	  vague,	  and	  the	  privately	  insured	  population	  still	  needs	  to	  be	  represented	  in	  the	  model.	  
4.2:	  Interventions	  and	  Costs	  Due	   to	   time	   constraints,	   we	   chose	   to	   work	   with	   healthcare	   interventions	   pertaining	   to	  general	  health	  and	  wellness,	  as	  more	  interventions	  can	  be	  added	  to	  the	  model	  as	  needed	  in	  the	   future.	   Companies	   using	   the	   cost-­‐benefit	   projection	   model	   will	   be	   able	   to	   select	  interventions	  they	  wish	  to	  consider	  implementing	  in	  their	  workplaces,	  and	  the	  model	  will	  calculate	   the	  cost/benefit	   ratio	  and	  produce	  a	  graph	   to	  visually	  present	   the	  results.	   	  This	  allows	  companies	  to	  make	  informed	  decisions	  as	  to	  whether	  they	  will	  implement	  wellness	  interventions	   in	   their	   workplaces.	   We	   found	   that	   it	   was	   difficult	   to	   standardize	   many	  interventions	   because	   costs	   vary	   by	   company	   depending	   on	   its	   size.	  We	  were	   unable	   to	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determine	  standard	  interventions	  as	  a	  result	  of	  this	  challenge.	  Based	  on	  the	  feedback	  from	  discussions	   at	   the	   workshop,	   we	   found	   that	   wellness	   managers,	   who	   are	   most	  knowledgeable	  about	  their	  workplace	  and	   its	  health	  situation,	  will	  be	  the	  primary	  source	  for	  adding	  their	  own	  interventions	  into	  the	  model.	  These	  interventions	  are	  likely	  to	  be	  the	  workplace	   wellness	   programs	   with	   which	   they	   are	   most	   familiar.	   The	   research	   we	  conducted	   provided	   a	   better	   understanding	   of	   the	   types	   of	   programs	   that	   wellness	  managers	  can	  include	  in	  the	  model.	  We	  focused	  on	  peer	  education	  and	  wellness	  screenings	  as	   interventions	   because	   the	   costs	  were	   readily	   available	   from	  NABCOA	   and	  WBCG,	   and	  they	   can	   be	   used	   to	   address	  multiple	   health	   problems	   identified	   by	   the	   epidemiological	  profile.	  	  
Peer	  education	   is	  a	  wellness	  service	   that	   is	  supported	  by	  organizations	   like	  NABCOA	  and	  WBCG.	  For	  a	   fee,	  which	  varies	  based	  on	   factors	  such	  as	   the	  cost	  of	   travel	   to	  a	  company’s	  location,	   lodging	   accommodations,	   and	   the	   salary	   of	   a	   trainer,	   companies	   can	   have	  representatives	   trained	   on	   how	   to	   become	   a	   peer	   educator	   in	   the	   workplace.	   Peer	  educators	  are	  responsible	  for	  holding	  a	  certain	  number	  of	  discussions	  on	  health	  topics	  that	  are	  specific	  to	  the	  needs	  of	  a	  company.	  For	  example,	  in	  a	  workplace	  where	  diabetes	  may	  be	  a	   prominent	   health	   issue,	   the	   peer	   educator	  would	   host	   informative	   sessions	   about	   how	  certain	  preventative	  measures	  against	  diabetes	  can	  be	  taken.	  
Listed	   in	   Table	   4.1	   is	   the	   breakdown	   of	   the	   total	   costs	   of	   NABCOA’s	   peer	   education	  programs.	  There	   are	  many	  variables	   that	   factor	   into	   the	  overall	   cost	   of	   a	   peer	   education	  training	  session.	  Our	  goal	  was	  to	  develop	  a	  standard	  cost	  for	  the	  intervention,	  but	  this	  was	  a	  challenge	  due	  to	  the	  variation	  in	  expenses	  for	  travel	  to	  a	  company’s	  location,	  the	  cost	  of	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the	   trainer’s	   wage,	   accommodations	   for	   the	   trainer,	   and	   several	   other	   factors.	   Each	  company	   would	   need	   to	   calculate	   these	   costs	   for	   their	   workplace,	   and	   then	   create	   an	  intervention	  in	  the	  model.	  	  This	  makes	  it	  difficult	  to	  develop	  an	  average	  cost	  that	  would	  be	  accurate	  for	  multiple	  companies.	  
Table	  4.1:	  Costs	  for	  Peer	  Education	  
Peer	  Education	  Local	  Trainer	  Fee	  Co-­‐Trainer	  Fee	  Trainer	  S&T	  Mileage	  Claim	  Stationary	  Pack	  Venue	  Fees	  Refreshment	  and	  Meal	  Costs	  Participation	  Costs	  	  	  Wellness	   screenings	   allow	   employees	   to	   be	   tested	   anonymously	   for	   a	   range	   of	   health	  problems,	   which	   may	   include	   HIV,	   high	   blood	   pressure,	   abnormal	   glucose	   levels,	   high	  cholesterol,	   low	   hemoglobin,	   or	   Hepatitis	   B.	   There	   are	   different	   wellness	   screening	  packages	   that	   vary	   in	   the	   number	   of	   tests	   included	   and	   are	   offered	   at	   a	   range	   of	   prices.	  Companies	  can	  have	  mobile	   testing	  units	   from	  organizations	  such	  as	  NABCOA	  and	  WBCG	  come	   directly	   to	   their	   work	   site	   to	   increase	   the	   accessibility	   of	   testing	   services	   to	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employees.	   The	   breakdown	   of	   the	   components	   that	   contribute	   to	   the	   total	   cost	   of	  Bophelo!’s	  wellness	  screenings	  are	  listed	  in	  Table	  4.2.	  
Table	  4.2:	  Bophelo!	  Costs	  for	  Wellness	  Screenings	  Bophelo!	  Mobile	  Clinic	  Wellness	  Screenings	  HIV	  Voluntary	  Counseling	  and	  Testing	  Full	  Wellness	  Screening	  Data	  Collection	  Report	  Writing	  KAPB	  Survey	  Staff	  Costs	  for	  Mobile	  Clinic	  Management	  Fee	  Mobile	  Units	  Travel	  (Estimated	  km)	  S&T	  Mobile	  Testing	  Team	  Accommodations	  	  
Implementation	  &	  Impact	  of	  Wellness	  Programs	  in	  the	  Workplace	  The	  goal	  of	  our	  interviews	  with	  Olthaver	  &	  List,	  a	  holding	  company	  that	  buys	  the	  shares	  of	  other	   businesses,	   and	   De	   Beers,	   a	   diamond	   mining	   company,	   was	   to	   obtain	   an	  understanding	  of	   the	   types	  of	  wellness	  programs	   in	  place	   in	   the	  private	   sector	   and	   their	  costs.	  We	   observed	   a	   large	   difference	   in	  wellness	   program	  monitoring	   between	   the	   two	  companies.	  	  The	  Wellness	  manager	  at	  Olthaver	  &	  List	  (O&L)	  was	  able	  to	  explain	  the	  different	  wellness	  programs	  and	  policies	   in	   the	  company’s	  workplaces	  but	  was	  unable	   to	  provide	  a	  cost	   for	  each	   specific	   program	   (H.	  Haimili,	   personal	   communication,	   April	   9th,	   2013).	   At	   O&L	   the	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wellness	   manager	   is	   responsible	   for	   providing	   programs	   from	   the	   company’s	   wellness	  budget	  to	  each	  of	  the	  companies	  under	  O&L.	  While	  the	  wellness	  manager	  elaborated	  on	  the	  variety	   of	   programs	   offered	   to	   each	   of	   the	   companies	   based	   on	   their	   locations	   and	  accessibility,	   there	   was	   no	   documentation	   regarding	   which	   programs	   had	   been	  implemented.	   The	  Wellness	   Manager	   also	   shared	   that	   there	   is	   no	   method	   of	   measuring	  effectiveness.	  	  
In	  contrast,	  the	  DeBeers	  wellness	  manager	  easily	  provided	  us	  with	  information	  on	  each	  of	  the	   many	   programs	   that	   DeBeers	   has	   used	   from	   2003	   to	   the	   present	   (E.	   Grötzinger,	  personal	  communication,	  April	  11,	  2013).	  Many	  of	   the	  programs	  were	  similar	   to	   those	  of	  O&L	   such	   as	   peer	   education	   programs	   and	  wellness	   screenings,	   but	   the	   programs	  were	  offered	  more	  frequently	  at	  DeBeers.	  The	  wellness	  programs	  at	  DeBeers	  are	  often	  held	  on	  a	  monthly,	  bi-­‐monthly,	  yearly,	  or	  on	  a	  case-­‐by-­‐case	  basis.	  Many	  of	  the	  programs	  such	  as	  on-­‐site	   clinics,	   offer	   employees	   improved	  accessibility	   as	  well.	   In	   addition	   to	   the	  plethora	  of	  programs	  DeBeers	  offers,	   the	  wellness	  manager	   clearly	  had	   strong	   trusting	   relationships	  with	   the	   800	   employees	   at	   DeBeers.	   These	   relationships	   can	   be	   used	   to	   promote	   the	  programs,	  as	  employees	  use	  services	  without	  fear	  of	  being	  stigmatized.	  	  	  
Wellness	   programs	   vary	   significantly	   between	   the	   two	   companies.	   Although	   both	  companies	  offer	  wellness	  programs	  promoting	  healthy	  lifestyles	  and	  offering	  opportunities	  to	  be	   tested	   for	   illnesses,	  DeBeers	  not	  only	  has	  control	  of	  each	  program	  and	  knows	  each	  cost,	   they	  also	  document	  the	  results	  of	  providing	  the	  programs	  to	  employees.	  The	  rate	  of	  absenteeism	  is	  under	  1%	  for	  employees	  since	  the	  implementation	  of	  a	  wellness	  program	  in	  2003	   and	   surveys	   are	   continually	   used	   to	   measure	   the	   effectiveness	   of	   programs.	   The	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differences	   between	   the	   two	   companies’	  wellness	   programs	   exemplify	   the	   effects	   strong	  wellness	  programs	  can	  have.	  
Interventions:	  Limitations	  and	  Future	  Developments	  Due	   to	   time	   constraints,	   our	   work	   with	   interventions	   was	   limited.	   There	   are	   many	  considerations	   that	   are	   involved	   in	   the	   process	   of	   standardizing	   interventions,	   including	  cost,	  practicality	  of	  implementation,	  and	  the	  projected	  effectiveness	  at	  reducing	  workplace	  morbidity	  and	  mortality.	  The	  WHO-­‐CHOICE	  website	  provided	  a	  number	  of	  suggested	  cost-­‐effective	   interventions	   for	   countries	   worldwide,	   but	   it	   was	   a	   challenge	   to	   make	   these	  interventions	  applicable	  to	  the	  Namibian	  workplace.	  For	  example,	  a	  possible	  WHO-­‐CHOICE	  intervention	  for	  HIV/AIDS	  is	  to	  provide	  Highly	  Active	  Anti-­‐Retroviral	  Therapy	  (HAART)	  to	  those	  who	  are	   infected.	  Some	  companies	  are	  not	  able	   to	  do	  this	   themselves,	  but	   they	  can	  provide	   employees	   who	   need	   treatment	   referrals	   to	   doctors	   capable	   of	   providing	   the	  treatments.	   While	   NABCOA	   aims	   to	   increase	   awareness	   of	   wellness	   and	   investment	   in	  workplace	  programs,	  the	  goal	  is	  not	  to	  replace	  an	  employer’s	  duties	  with	  those	  of	  a	  health	  practitioner.	   Some	   of	   these	  WHO-­‐CHOICE	   interventions	   could	   potentially	   be	  modified	   to	  providing	  a	  doctor	  referral	  for	  treatment,	  rather	  than	  attempting	  to	  provide	  the	  treatment.	  We	  were	  able	  to	  identify	  two	  possible	  interventions	  from	  WHO-­‐CHOICE	  that	  could	  be	  used	  in	   the	  workplace,	   which	  were	   Voluntary	   Counseling	   and	   Testing	   (VCT)	   and	  mass	  media	  education,	  as	  potential	  workplace	  interventions	  as	  provided	  by	  the	  WHO	  data.	  Although	  we	  did	  not	  develop	  the	  WHO-­‐CHOICE	  interventions	  so	  that	  they	  could	  be	  used	  in	  the	  model,	  we	  continued	  to	  find	  the	  annual	  costs	  per	  person	  for	  each	  intervention,	   listed	  in	  Appendix	  G.	  Over	   time	   these	   interventions	   can	   be	   developed	   to	   suit	   the	  workplace	   and	   added	   to	   the	  model	  so	  that	  there	  will	  be	  more	  intervention	  options	  for	  companies	  to	  choose	  from.	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Overall,	  many	  of	  the	  WHO-­‐CHOICE	  interventions	  closely	  corresponded	  to	  health	  issues	  that	  were	  identified	  in	  the	  epidemiological	  profile.	  For	  example,	  tuberculosis,	  HIV/AIDS,	  alcohol	  consumption,	   tobacco	   use,	   and	   high	   cholesterol	   are	   all	   addressed	   with	   WHO-­‐CHOICE	  interventions.	  While	  other	  health	   issues	   included	   in	   the	  model	   can	  be	   related	   to	   a	  WHO-­‐CHOICE	  intervention,	  none	  of	  these	  overall	  top	  five	  issues	  are	  reflected	  in	  the	  interventions	  that	  the	  WHO-­‐CHOICE	  project	  recommends.	  
Our	  greatest	  challenge	  was	  determining	  the	  reduction	  in	  morbidity	  and	  mortality	  rates	  that	  would	  result	  from	  each	  intervention.	  There	  were	  no	  reports	  to	  use	  as	  references,	  as	  there	  have	  not	  been	  many	  studies	  published	  on	   these	   topics	   in	  Namibia	  or	   internationally.	   	  To	  determine	   values	   for	   these	   two	   variables,	  wellness	  managers	  will	   have	   to	   use	   their	   best	  judgment	  and	  estimate	  rates	  based	  on	  their	  experience	  with	  the	  intervention.	  Additionally,	  the	  wellness	  managers	   are	   responsible	   for	   determining	   the	   duration	   of	   the	   intervention,	  the	   coverage,	   and	   the	   annual	   cost	   per	   employee.	   Each	   of	   these	   values	   will	   vary	   from	  company	  to	  company	  depending	  on	  its	  number	  of	  employees	  and	  the	  health	  problems	  that	  are	  being	  addressed.	  
In	  the	  next	  chapter	  of	  this	  report,	  we	  will	  present	  final	  conclusions	  about	  the	  findings	  we	  obtained	  during	  the	  development	  of	  the	  cost-­‐benefit	  projection	  model	  and	  our	  recommendations	  on	  areas	  where	  the	  model	  can	  be	  improved.	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Chapter	  5:	  Conclusions	  and	  Recommendations	  In	   this	   chapter	  we	  will	  present	  our	   conclusions	  and	   recommendations	   to	   aid	  NABCOA	   in	  the	   further	  development	  of	   the	   cost-­‐benefit	   projection	  model.	  Based	  on	  our	   analysis	   and	  feedback	  collected	  from	  the	  cost-­‐benefit	  projection	  model	  workshop	  and	  training	  sessions	  held	   April	   22nd-­‐26th,	   2013,	   we	  were	   able	   to	   develop	   a	   stronger	   understanding	   of	   where	  improvements	   should	   be	   made.	   We	   will	   discuss	   in	   more	   detail	   a	   brief	   summary	   of	   our	  findings,	   our	   conclusions,	   and	   final	   recommendations	   for	   how	   NABCOA	   should	   best	  continue	  with	  the	  development	  and	  piloting	  of	  the	  projection	  model.	  
5.1	  Summary	  of	  Findings	  Once	   the	   appropriate	   data	   were	   collected,	   we	   were	   able	   to	   develop	   an	   epidemiological	  profile	   that	   identified	   the	   top	   causes	   of	  morbidity	   and	  mortality,	   as	  well	   as	   the	   top	   risk	  factors	  for	  the	  Namibian	  working	  age	  population.	  Using	  the	  incidence	  and	  prevalence	  rates	  from	   the	   epidemiological	   profile,	   the	  model	   projected	   the	   top	   health	   problems	   based	   on	  lost	  workdays.	  However,	  there	  were	  some	  limitations	  with	  the	  data	  that	  can	  be	  reduced	  so	  that	  the	  model	  will	  make	  more	  accurate	  calculations.	  
The	  data	  we	  collected	  provides	  a	  strong	  foundation	  for	  the	  epidemiological	  component	  of	  the	  model,	  there	  are	  several	  limitations.	  First,	  the	  morbidity	  data	  from	  the	  MoHSS	  was	  not	  gender	  specific.	  The	  model	  works	  optimally	  with	  gender	  specific	  data	  because	  it	  provides	  more	  precise	  calculations	  for	  health	  problems	  that	  may	  occur	  more	  frequently	  among	  one	  gender.	   The	  model	   currently	   does	  not	   represent	   the	  privately	   insured	  population,	   as	   the	  MoHSS	  data	  was	  collected	  from	  public	  hospitals.	  Also,	  the	  MoHSS	  data	  may	  be	  biased	  due	  to	  underreporting	  or	  misreporting	  of	  causes	  of	  death	  or	  disease.	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By	  determining	  common	  workplace	  interventions	  and	  the	  information	  necessary	  for	  their	  integration	   into	   the	  model,	  we	   found	   that	   the	   costs	  were	   a	   very	   important	   aspect	   of	   the	  interventions.	   Comparing	   the	   costs	   of	   different	   interventions	   from	   the	   WHO-­‐CHOICE	  project,	  NABCOA,	  and	  WBCG,	  we	  found	  that	  costs	  vary	  greatly	  depending	  on	  the	  size	  and	  location	  of	   the	  company.	  Thus,	  we	   found	   that	   it	   is	  essential	   that	  companies	  keep	   track	  of	  these	   costs,	   as	  well	   as	   the	   effects	   that	   interventions	   have	   on	   reducing	   the	  mortality	   and	  morbidity	  rates	  of	  health	  problems.	  
Based	   on	   these	   findings	   and	   limitations,	   we	   made	   several	   conclusions	   and	  recommendations	  that	  aim	  to	  continue	  improving	  the	  cost-­‐benefit	  projection	  model.	  	  
5.2	  Conclusions	  and	  Key	  Characteristics	  The	   completed	  model	   is	   capable	  of	  providing	   employers	  with	   the	   top	   reasons	   for	   loss	  of	  productivity	  in	  the	  workplace.	  After	  analyzing	  the	  data	  we	  gathered,	  we	  have	  come	  to	  some	  conclusions	  that	  we	  will	  use	  to	  provide	  recommendations	  to	  NABCOA	  to	  assure	  the	  model’s	  continued	  improvement.	  
In	  light	  of	  the	  challenges	  we	  had	  collecting	  data,	  one	  of	  the	  largest	  issues	  is	  the	  accessibility	  of	  health	  data	  in	  Namibia.	  Specifically,	  when	  trying	  to	  locate	  the	  relevant	  data	  needed	  from	  the	   MoHSS,	   we	   found	   that	   information	   was	   scattered	   among	   different	   sources	   and	  databases.	   In	  particular,	  we	  had	  difficulty	   finding	   information	  on	  causes	  of	  morbidity	  and	  mortality.	  Because	  of	   the	  organization	  of	   the	  data,	  we	  waited	  an	  extended	  period	  of	   time	  before	  receiving	  the	  information	  that	  the	  model	  requires.	  
Additionally,	  available	  data	  is	  often	  too	  broadly	  categorized.	  For	  example,	  the	  top	  causes	  of	  morbidity	  and	  mortality	  included	  “other	  diagnosis”	  categories,	  which	  gives	  no	  definition	  of	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the	   specific	   health	   problem.	   This	  makes	   it	   difficult	   to	   identify	   the	   exact	   health	   problems	  responsible	  for	  reducing	  productivity	  in	  the	  workplace.	  	  
During	  the	  workshops	  and	  trainings	  we	  saw	  that	  the	  model	  is	  versatile	  in	  that	  it	  is	  capable	  of	   being	   adapted	   to	   suit	   the	   specific	   needs	   of	   companies.	   Employers	   can	   change	   the	  epidemiological	  profile	  to	  reflect	  the	  health	  profile	  of	  their	  companies	  if	  they	  have	  the	  data	  available.	  Since	  the	  model	  is	  currently	  populated	  with	  national	  data,	  this	  option	  of	  tailoring	  the	  model	  would	  allow	  for	  the	  calculations	  to	  be	  extremely	  accurate,	  as	  the	  population	  of	  the	  data	  would	  be	  based	  solely	  on	  the	  company.	  
When	  the	  epidemiological	  profile	  and	  interventions	  were	  presented	  to	  private	  and	  public	  sector	   representatives	   at	   workshop	   sessions,	   April	   22nd-­‐23rd,	   2013,	   the	   information	  was	  well	  received	  by	  the	  group	  of	  attendees.	  Four	  out	  of	  five	  wellness	  managers	  expressed	  their	  interest	   in	  piloting	   the	  projection	  model	   in	   the	  near	   future.	  These	  responses	  are	  a	  strong	  indicator	  that	  the	  projection	  model	  is	  appealing	  to	  stakeholders.	  This	  workshop	  prompted	  helpful	   recommendations	   to	   strengthen	   the	   model,	   which	   we	   will	   discuss	   in	   detail	   in	  section	  5.3.	  
5.3	  Recommendations	  Based	   on	   our	   findings	   and	   conclusions,	  we	   have	   developed	   several	   recommendations	   to	  ensure	  that	  the	  model	  continues	  to	  be	  well	  maintained	  and	  further	  developed	  throughout	  the	  piloting	  process.	  
To	  make	  data	  more	  accessible,	  we	  recommend	  that	  NABCOA	  and	  GIZ	  express	  interest	  
in	   merging	   the	   MoHSS	   databases	   into	   one	   comprehensive	   database.	   There	   are	  currently	  over	  60	  databases	  with	   information	   from	  various	  MoHSS	  divisions.	  A	  variety	  of	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information	  is	  included	  in	  these	  databases,	  however	  it	  is	  difficult	  to	  easily	  locate	  data	  due	  to	  a	   lack	  of	  organization.	  To	  help	   facilitate	  data	  collection	  and	  make	   it	  more	  efficient,	   the	  databases	   should	   be	   assessed	   to	   determine	   what	   information	   they	   contain.	   This	   could	  potentially	   become	   a	   joint	   project	   with	   NABCOA	   and	   the	   MoHSS.	   	   If	   steps	   are	   taken	   to	  organize	   country	   specific	   data,	   especially	   so	   that	   it	   is	   gender	   specific,	   age	   specific,	   and	  health	   issue	   specific,	   then	   collecting	   accurate	   data	   for	   the	   epidemiological	   profile	   will	  become	  a	  much	  simpler	  process.	  	  
The	   epidemiological	   profile	   should	   be	   updated	   as	   more	   relevant	   data	   become	  
available.	   Over	   time,	   health	   problems	   will	   vary	   in	   prevalence	   based	   on	   outbreaks	   or	  successful	  national	  health	   interventions.	   It	   is	   important	   to	  keep	   these	  rates	  up	   to	  date	  so	  that	   the	  model	  makes	   accurate	   calculations.	   One	   potential	   source	   of	   information	   for	   the	  profile	  is	  the	  Demographic	  Health	  Survey	  for	  Namibia,	  which	  has	  a	  projected	  release	  date	  of	  June/July	  2013,	  and	  may	  be	  used	  to	  obtain	  more	  current	  data.	  To	  help	  NABCOA	  transition	  from	  the	  work	  we	  have	  done	  collecting	  data	   to	   the	   future	  updates	   for	  which	   they	  will	  be	  responsible,	   we	   have	   identified	   several	   starting	   points,	   including:	   focusing	   on	   finding	  gender-­‐specific	  morbidity	   data,	   determining	   the	   specific	   health	   problems	   included	   in	   the	  broad	  health	   categories	   for	  mortality	   and	  morbidity	   causes,	   and	   incorporating	  data	   from	  the	  privately	  insured	  population.	  
A	   NABCOA	   employee	   should	   be	   assigned	   to	   monitor	   the	   model	   and	   update	   it	   as	  
needed.	  Our	  team	  has	  provided	  NABCOA	  with	  a	  standard	  data	  request	  form	  that	  outlines	  all	   the	   data	   used	   in	   the	   model.	   This	   form	   can	   be	   located	   in	   Appendix	   H.	   We	   have	  summarized	   the	   specific	   data	   needed	   for	   each	   section	   of	   the	   epidemiological	   profile	   in	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another	  effort	  to	  simplify	  the	  data	  collection	  process.	  When	  requesting	  data,	  the	  form	  can	  be	   distributed	   to	   sources	   like	   the	   MoHSS	   or	   medical	   aid	   insurers	   so	   that	   there	   is	   no	  miscommunication	  regarding	  the	  kinds	  of	  data	  being	  requested.	  
When	  data	  becomes	  available,	   the	  model	  should	  be	  tailored	  to	  different	   industries,	  
sectors,	  and	  regions	  of	  Namibia.	  To	  do	  this,	  the	  data	  in	  the	  epidemiological	  profile	  would	  be	  replaced	  so	  that	  it	  reflects	  health	  problems	  that	  are	  most	  common	  in	  Namibia’s	  specific	  industries,	  sectors,	  or	  regions.	  This	  will	  target	  the	  specific	  needs	  of	  companies,	  and	  would	  be	   especially	   useful	   for	   companies	  with	   unique	   occupational	   health	   risks.	   Certain	   health	  problems	  vary	  by	  region,	  for	  example	  malaria	  is	  only	  an	  issue	  in	  the	  northern	  parts	  of	  the	  country,	   and	   so	   the	   incidence	   and	   prevalence	   rates	  will	   slightly	   differ	   from	   the	   national	  data.	  The	  idea	  of	  a	  model	  containing	  regional	  or	  industry	  specific	  data	  was	  well	  received	  at	  the	  model’s	  training	  program.	  	  
We	  recommend	  that	  NABCOA	  follow	  up	  monthly	  with	  companies	  piloting	  the	  model.	  The	   success	   of	   interventions	   must	   be	   monitored	   closely	   to	   identify	   their	   effects	   on	   the	  workforce.	   NABCOA	   members	   should	   therefore	   be	   diligent	   in	   keeping	   contact	   with	   the	  wellness	   managers	   piloting	   the	   model.	   These	   follow	   ups	   should	   be	   geared	   toward	  addressing	  any	  questions	  or	  concerns	  employers	  may	  have	  and	  making	  sure	  that	  data	  on	  the	   effects	   of	   interventions	   on	   morbidity	   and	   mortality	   is	   being	   collected	   carefully.	  Maintaining	   the	   communication	   between	   NABCOA	   and	   the	   piloting	   companies	   will	   help	  sustain	  interest	  in	  the	  model,	  prevent	  the	  loss	  of	  data,	  and	  help	  to	  identify	  where	  the	  model	  can	  be	  improved.	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To	   promote	   the	  model	   and	   the	   training	   programs	   during	   piloting	   and	   launch,	   we	  
recommend	   that	  NABCOA	  market	   the	  model	   in	   the	   private	   sector.	  This	  can	  be	  done	  during	   peer	   education	   trainings	   where	   NABCOA	   trainers	   can	   mention	   the	   model	   to	  attendees.	   Another	   potential	  method	   of	  marketing	   is	   through	  NABCOA’s	   newsletters	   and	  newspaper	   advertisements.	   Promotion	   efforts	   will	   not	   only	   be	   beneficial	   for	   spreading	  awareness	  about	   the	  model,	  but	  also	   for	  endorsing	  NABCOA’s	  growing	  programs.	   In	   turn	  effective	   advertising	   can	   potentially	   increase	   company	   membership	   with	   NABCOA.	  Similarly,	  the	  model	  can	  be	  promoted	  by	  the	  Bophelo!	  Mobile	  Wellness	  Clinics.	  Since	  these	  mobile	  clinics	  travel	  across	  the	  country	  to	  different	  regions,	  marketing	  the	  model	  to	  these	  groups	  will	  target	  a	  larger	  audience	  and	  can	  increase	  the	  model’s	  use	  to	  companies	  across	  Namibia.	  	  
GIZ	   plans	   to	   adapt	   the	   model	   to	   a	   web-­‐based	   format.	   We	   strongly	   support	   this	  
initiative,	  since	  during	  the	  training	  sessions	  there	  were	  some	  technical	  errors	  with	  Excel	  when	   using	   the	  model.	   Depending	   on	   the	   version	   of	   Excel	   software,	   the	  model	   was	   not	  always	  fully	  compatible.	  An	  online	  template	  that	  does	  not	  require	  a	  software	  download	  and	  is	  compatible	  with	  any	  operating	  system	  would	  be	  ideal	  and	  allow	  for	  the	  model	  to	  be	  used	  to	  its	  fullest	  potential	  by	  anyone	  who	  could	  access	  the	  webpage.	  	  
Each	  of	  these	  recommendations	  will	  strengthen	  the	  model	  by	   increasing	  data	  availability,	  making	   use	   of	   its	   versatility,	   and	   preparing	   for	   the	   piloting	   process.	   The	   cost-­‐benefit	  projection	  model	  has	  been	  a	  success	  in	  Ghana,	  Kenya,	  and	  Tanzania,	  and	  can	  have	  a	  great	  impact	   in	  Namibia.	  By	   informing	  companies	  of	   the	   financial	  benefits	   that	   can	   result	   from	  investment	   in	   healthcare,	   the	   model	   promotes	   the	   concept	   that	   healthcare	   should	   be	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thought	  of	  as	  an	  economically	  justified	  business	  decision	  in	  addition	  to	  an	  ethical	  one.	  It	  is	  an	   innovative	   tool	   that	   has	   the	   potential	   to	   encourage	   private	   and	   public	   sector	  involvement	   in	   healthcare,	   make	   wellness	   services	   readily	   available	   to	   more	   of	   the	  population,	  and	  improve	  the	  overall	  accessibility	  of	  healthcare	  to	  the	  Namibian	  population.	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Appendix	  A:	  Sponsor	  Description	  For	  over	  a	  decade,	  the	  Namibia	  Business	  Coalition	  on	  AIDS	  (NABCOA)	  has	  been	  committed	  to	   developing	   HIV/AIDS	   programs	   aimed	   at	   managing	   the	   growing	   epidemic	   in	   the	  Namibian	   workplace	   (P.	   van	   Wyk,	   personal	   communication,	   April	   30,	   2013).	   	   Recently,	  NABCOA	   has	   shifted	   the	   focus	   of	   their	   programs	   to	   incorporate	   general	   health	   and	  wellness.	   Many	   of	   these	   programs	   are	   made	   available	   to	   the	   Namibian	   private	   sector	  through	  membership	  enrollment	  with	  NABCOA.	  With	  the	  aim	  of	  targeting	  wellness	  through	  workplace	  programs,	  NABCOA	  brings	  awareness	  to	  varying	  health	  problems	  that	  can	  affect	  employees.	  One	  of	  the	  organization’s	  forefront	  challenges	  is	  to	  increase	  investment	  of	  the	  private	  sector	   in	  their	  workplace	  wellness	  programs	  (WPP)	  as	  well	  as	  provide	  them	  with	  an	  understanding	  of	  the	  benefits	  following	  investment.	  	  
Through	  these	  programs,	  NABCOA	  unifies	  a	  variety	  of	  local	  businesses	  that	  have	  expressed	  interest	   in	   health	   and	   wellness	   (World	   Economic	   Forum,	   2008).	   The	   organization	   was	  originally	   founded	   in	   November	   2002	   by	   ten	   founding	  members,	   and	   began	   to	   formally	  offer	   its	   services	   in	   June	  2003.	  According	   to	   the	  CEO	  of	  NABCOA,	  Peter	  van	  Wyk	   (2013),	  NABCOA	  currently	  has	  50	  members	  from	  a	  wide	  range	  of	  industries	  (e.g.	  Namibia	  Talanam	  Fish	  Processors,	  AVBOB	  Funerals,	  Trau	  Bros	  Diamonds,	  etc.).	  	  	  	  
NABCOA’s	   members	   can	   be	   classified	   into	   five	   different	   tiers	   depending	   on	   their	   size:	  small/medium	   sized	   companies	   (less	   than	   100	   employees),	   large	   companies	   (101-­‐250	  employees),	   corporate	   (over	   250	   employees),	   and	   founder	   (P.	   van	   Wyk,	   personal	  communication,	   April	   30,	   2013).	   Founder	   companies	   are	   typically	   the	   same	   size	   as	  corporate	   companies	   but	   provide	   a	   larger	   contribution	   in	   fees	   and	   are	   therefore	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recognized.	  NABCOA	  (2012)	  presently	  recognizes	  fourteen	  “Founder	  Members”:	  Ohlthaver	  and	  List	  Group	  of	  Companies	  (O&L),	  Shell	  Namibia,	  Bank	  Windhoek,	  BP	  Namibia,	  Namibia	  Institute	  of	  Pathology	  (NIP),	  Coca-­‐Cola	  Namibia	  Bottling	  Company,	  UNDP,	  NAMDEB,	  City	  of	  Windhoek,	  NAMPOWER,	  Standard	  Bank	  Namibia,	  SANLAM,	  NANASO,	  and	  UNAIDS.	  
The	   internal	   structure	  of	  NABCOA	   is	   currently	   composed	  of	   24	   staff	  members	  occupying	  eight	   different	   positions	   (P.	   van	   Wyk,	   personal	   communication,	   April	   30,	   2013).	   These	  positions	   are	   distributed	   among	   three	   divisions	   within	   NABCOA:	   programmatic,	  finance/administration,	  and	  wellness.	  	  
These	  divisions	  help	  NABCOA	   to	  offer	  health	   services	   to	   its	  members.	  NABCOA	  regularly	  hosts	  informative	  events	  around	  the	  country	  to	  engage	  members	  at	  various	  locations	  (van 
Wyk, 2008). NABCOA	   has	   the	   resources	   to	   send	   its	   own	   educated	   professionals	   to	   these	  events	   to	   train	   others	   in	   peer	   education,	   workplace	   HIV/wellness	   programs,	   policy	  development,	   affordable	   healthcare,	   and	   anti-­‐retroviral	   treatment.	  Workshops,	   refresher	  seminars,	   and	   training	   sessions	   are	   also	   common	   services	   provided.	   Other	   resources	  include	  providing	  information	  and	  spreading	  awareness	  through	  its	  newsletter,	  providing	  cost-­‐benefit	   analysis	   to	   participating	   businesses,	   and	   the	   ability	   to	   carry	   out	   research	  projects	  relevant	  to	  its	  mission.	  Members	  of	  the	  coalition	  can	  choose	  how	  extensively	  they	  participate	   in	   NABCOA’s	   education	   programs.	   NABCOA’s	   membership	   is	   comprised	   of	  certain	  businesses	  that	  routinely	  partake	  in	  the	  offered	  services,	  and	  others	  who	  are	  not	  as	  actively	  involved.	  
There	  are	  also	  other	  organizations	   in	  Namibia	  that	  address	  various	  health	  problems	  such	  as	   HIV/AIDS	   and	   overall	   wellness	   in	   the	   workplace	   (World	   Economic	   Forum,	   2008).	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NABCOA	   has	   some	   partner	   implementers	   in	   achieving	   this	   goal,	   including	   the	   Namibia	  Networks	  of	  AIDS	  Service	  Organization	  (NANSO)	  and	  the	  Alliance	  of	  Mayors	  and	  Municipal	  Leaders	  (AMICAALL).	  NABCOA	  is	  also	  a	  founding	  member	  of	  Pan	  Africa	  Business	  Coalition	  (PABC).	  Other	  cooperating	  partners	  of	  NABCOA	  (2012)	  include	  GIZ,	  The	  Global	  Fund,	  KNCV	  Tuberculosis	  Foundation	  &	  United	  States	  Agency	   for	   International	  Development	   (USAID),	  Sustainable	   Health	   Outcomes	   in	   the	   Private	   Sector	   (SHOPS),	   and	   Namibia’s	   Ministry	   of	  Health	  and	  Social	  Services	  (MoHSS).	  	  
In	  2003,	  NABCOA	  partnered	  with	  GIZ,	  a	  German	  government	  agency,	  to	  assist	  in	  NABCOA’s	  development	   of	  HIV/AIDS	  programs	   and	  projects.	   This	   relationship	   has	   remained	   strong	  for	  10	  years	  as	  GIZ	  continues	  to	  work	  closely	  with	  NABCOA	  by	  providing	  technical	  advisors	  and	   local	   professionals.	   They	   also	   assist	   in	   financing	   projects	   focused	   on	   researching,	  monitoring,	  and	  evaluating	  workplace	  programs.	  GIZ	  has	  a	  HIV/AIDS	  team	  of	  individuals	  in	  Namibia	  who	  assist	  organizations	   such	  as	  NABCOA	  with	  various	  programs.	  GIZ	   currently	  operates	  with	  over	  130	  partnering	  companies	  and	  organizations	  worldwide	  to	  develop	  and	  offer	   services	   for	   sustainable	   development,	   The	   project	   team	   worked	   very	   closely	   with	  NABCOA’s	   current	   technical	   advisor,	   Matthew	   Black,	   a	   consultant	   funded	   by	   GIZ,	   and	  Beatrix	  Akuake,	  the	  Workplace	  Programme	  and	  Project	  Manager.	  
NABCOA	  partners	  with	   different	   organizations	   to	   complete	   various	   projects	   (Guariguata,	  deBeer,	  Hough,	  Bindels,	  Weimers-­‐Maasdorp,	  Feeley	  &	  Rinke	  de	  Wit,	  2012).	  A	  major	  project	  that	  has	  been	   implemented	   is	   the	  Bophelo!	  Project,	  which	  piloted	  one	  of	   the	   first	  mobile	  wellness	   screening	   clinics	   in	  Namibia.	  NABCOA	  achieved	   this	   through	  a	  partnership	  with	  the	  PharmAccess	  Foundation	  and	  the	  Namibian	  Institute	  of	  Pathology	  under	  the	  support	  of	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the	  Ministry	  of	  Health	  and	  Social	  Services.	  These	  mobile	  clinics	  travel	  to	  companies	  across	  Namibia	  to	  screen	  employees	  for	  a	  list	  of	  health	  measures.	  Within	  the	  NABCOA	  office,	  there	  are	  10	  employees	  who	  work	  very	  closely	  with	  Bophelo!	  as	  clinic	  supervisors,	  coordinators,	  and	  testers.	  	  	  
Other	   similar	   organizations	   to	   NABCOA	   in	   Namibia	   include	   the	   National	   Association	   of	  Planned	  Parenthood	  (NAPPA)	  and	  several	  faith	  related	  organizations,	  such	  as	  Catholic	  AIDS	  Action	   (CAA)	   (O’Hanlon,	   Barbara,	   Feeley,	   de	   Beer,	   Sulzbach	   &	   Vincent,	   2010).	   There	   are	  also	  similar	  private,	  for-­‐profit	  organizations	  such	  as	  Namibian	  Employers	  Federation	  (NEF)	  and	   National	   Union	   of	   Namibian	   Workers	   (NUNW).	   These	   companies	   also	   support	  HIV/AIDS	  and	  general	  wellness	  services	  for	  people	  in	  Namibia.	  






Appendix	  B:	  What	  is	  a	  Cost-­‐Benefit	  Projection	  Model?	  In	  order	  to	  promote	  the	  implementation	  of	  workplace	  programs	  targeting	  wellness	  within	  the	   private	   sector,	   evidence	   identifying	   the	   financial	   benefits	   of	   workplace	   wellness	  programs	  is	  needed	  (Lodemann,	  2013).	  This	  can	  be	  done	  through	  the	  use	  of	  a	  cost	  benefit	  projection	  model,	  a	  mathematical	  tool	  that:	  
• Defines	   the	  most	  prominent	  health	  problems	  affecting	   the	  Namibian	  workplace	   in	  an	  epidemiological	  profile	  
• Calculates	  loss	  of	  productivity	  in	  terms	  of	  costs	  of	  workdays	  lost	  due	  to	  absenteeism	  and	  presenteeism	  
o Absenteeism	  refers	  to	  employees	  being	  absent	  from	  work	  
o Presenteeism	  refers	  to	  employees	  being	  unproductive	  while	  at	  work	  	  
• Evaluates	   the	   interventions	   for	   their	   cost	   effectiveness	   based	   on	   their	   costs	   and	  reduction	  in	  morbidity	  and	  mortality	  
When	  utilizing	  the	  model,	  employers	  input	  company	  specific	  data,	  such	  as	  numbers	  of	  male	  and	  female	  employees	  and	  the	  costs	  of	  the	  salaries	  of	  employees	  into	  the	  ‘input	  parameters’	  section	  of	  the	  model	  (Lodemann,	  2013).	  Then	  the	  company	  can	  choose	  an	  intervention	  to	  evaluate	  for	  its	  cost	  effectiveness.	  	  
There	  are	  two	  main	  components	  to	  the	  projection	  model:	   the	  epidemiological	  profile	  and	  the	  interventions	  section	  (Lodemann,	  2013).	  First,	  the	  epidemiological	  profile	  identifies	  the	  most	  prevalent	  health	  issues	  for	  the	  specific	  country	  in	  which	  use	  of	  the	  tool	  is	  intended.	  It	  is	  comprised	  of	  three	  main	  parts:	  
• Top	  causes	  of	  morbidity	  (sickness)	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• Top	  causes	  of	  mortality	  (death)	  
• Top	  risk	  factors	  (health	  conditions	  that	  may	  lead	  to	  more	  serious	  illness)	  
Each	  cause	  of	  morbidity	  and	  mortality	   is	  provided	  in	  terms	  of	   its	   incidence	  rate,	  which	  is	  the	   number	   of	   new	   cases	   of	   a	   disease	  within	   a	   specific	   time	   period.	   The	   risk	   factors	   are	  measured	  by	  their	  prevalence	  rate,	  the	  measure	  of	  the	  total	  number	  of	  cases	  of	  a	  disease	  at	  any	   given	   time	   period	   within	   a	   population	   (Lodemann,	   2013).	   The	   model	   also	   uses	  standard	  values	  of	   the	  annual	  unproductive	  days	  as	  a	  result	  of	   the	  top	  risk	   factors.	  Using	  this	  country	  specific	  epidemiological	  information	  along	  with	  the	  company	  information	  that	  was	  entered,	  the	  model	  will	  provide	  values	  for	  predicted	  work	  days	  lost	  due	  to	  absenteeism	  from	   sickness,	   the	   costs	   for	   the	   company	   from	   the	   lost	   workdays,	   and	   the	   costs	   due	   to	  presenteeism	  from	  morbidity.	  With	  this	  knowledge	  of	  the	  health	  problems	  leading	  to	  a	  loss	  of	  productivity	  at	  the	  workplace	  supplies	  employers	  with	  the	  evidence	  necessary	  to	  begin	  evaluating	  what	  wellness	  programs	  can	  benefit	  the	  company.	  	  
Also	   in	   the	   model	   is	   a	   list	   of	   interventions,	   which	   are	   possible	   wellness	   services	   that	  companies	  can	  offer	  to	  employees,	  and	  their	  costs	  (Lodemann,	  2013).	  Employers	  may	  plug	  in	  information	  on	  their	  own	  interventions	  that	  they	  wish	  to	  evaluate.	  The	  model	  will	  then	  calculate	   the	   savings	   per	   intervention.	   This	   is	   calculated	   using	   the	   costs	   of	   interventions	  and	  the	  reduction	  in	  morbidity	  and	  mortality	  that	  the	  interventions	  yield.	  	  
Ultimately,	   the	   cost	   benefit	   projection	  model	   is	   an	   informative	  mathematical	   tool	   that	   is	  capable	  of	   supplying	   companies	  with	   relevant	   information	   concerning	   the	  health	  of	   their	  employees	   as	   well	   as	   how	   they	   can	   be	   affected	   by	   various	   illnesses	   and	   risk	   factors.	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   1. (For	  Ohltaver	  &	  List	  only):	  From	  the	  company	  website	  we	  found	  a	  list	  of	  wellness	  initiatives,	  could	  you	  provide	  a	  basic	  description	  of	  what	  each	  entails?	  	  •	   O&L	  Vitality	  Program	  •	   Absenteeism	  Management	  •	   Executive	  Wellness	  Program	  •	   Wellness	  Awareness	  sessions	  at	  Operating	  Companies	  •	   Wellness	  Information	  corners	  at	  every	  Operating	  Company	  •	   Wellness	  Screening	  and	  voluntary	  Counselling	  and	  Testing	  •	   Peer	  Education	  Program	  •	   Commemoration	  of	  International	  Health	  Days	  •	   Wellness	  Care	  and	  Support	  •	   Wellness	  site	  visits	  	   2. What	  was	  the	  initial	  investment	  in	  the	  initiative/program?	  	  	   3. What	   are	   the	   annual	   costs	   for	   each	   initiative/program?	   The	   annual	   cost	   per	  employee?	  
	   4. Is	  there	  a	  separate	  training	  cost	  for	  some	  of	  the	  programs?	  	   5. If	  incentives	  are	  used,	  were	  those	  costs	  factored	  into	  the	  final	  cost	  of	  the	  program	  or	  are	  they	  separate?	  	   6. How	  long	  do	  the	  programs	  run	  for?	  Months?	  Years?	  	   7. Any	  there	  any	  other	  costs	  associated	  with	  the	  programs?	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Appendix	  D:	  Mortality	  Rates	  Tables	  D.1	  and	  D.2	  give	  the	  rates	  of	  the	  top	  ten	  causes	  of	  mortality	  for	  Namibian	  males	  and	  females.	  The	  rates	  are	  given	  in	  the	  standard	  health	  data	  format	  of	  per	  1000	  people.	  
Table	  D.1:	  Namibia’s	  Top	  10	  Mortality	  Rates	  for	  Males	  
Mortality	  Cause	   Mortality	  Rate	  	  
(per	  1000	  population)	  
%	  of	  Total	  
Leading	  
Causes	  Pulmonary	  Tuberculosis	   0.970	   23.21	  HIV/AIDS	   0.821	   19.65	  Pneumonia	   0.713	   17.06	  Diarrhea,	  Gastroenteritis	   0.528	   12.64	  Heart	  Failure	   0.283	   6.78	  Other	  Respiratory	  System	  Diseases	   0.192	   4.61	  Hypertension	   0.184	   4.42	  Stroke,	  Intracranial	  Hemorrhage,	  Cerebral	  Infraction	   0.184	   4.42	  Anemia	   0.168	   4.04	  Diabetes	  Mellitus	   0.114	  	   2.75	  
	  
	  
Table	  D.2:	  Namibia’s	  Top	  10	  Mortality	  Rates	  for	  Women	  
Mortality	  Cause	   Mortality	  Rate	  
(per	  1000	  population)	  
%	  of	  Total	  
Leading	  
Causes	  HIV/AIDS	   0.693	   19.6	  Pulmonary	  Tuberculosis	   0.574	   16.2	  Pneumonia	   0.528	   15.0	  Diarrhea,	  Gastroenteritis	   0.415	   11.8	  Heart	  Failure	   0.338	   9.6	  Hypertension	   0.255	   7.2	  Stroke,	  Intracranial	  Hemorrhage,	  Cerebral	  Infraction	   0.224	   6.4	  Anemia	   0.196	   5.6	  Other	  Respiratory	  System	  Diseases	   0.175	   5.0	  Malignant	  Neoplasm	  of	  Cervix	  Uteri,	  Uterus,	  Ovaries	   	  0.113	   3.2	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Appendix	  E:	  Morbidity	  Rates,	  In/Outpatient	  Ratios,	  and	  
Hospital	  Stay	  Lengths	  Table	  E.1	  gives	  the	  top	  outpatient	  morbidity	  rates	  per	  1000	  of	  the	  population	  for	  males	  and	  females.	  	  
Table	  E.1:	  Namibia’s	  Top	  Morbidity	  Rates	  for	  Males	  and	  Females	  
	  
Morbidity	  Cause	  
Male	  Incidence	  Rate	  




population)	  Musculoskeletal	  System	  Disorder	   398.70	   398.70	  Other	  Respiratory	  Disease	   278.90	   278.90	  Trauma	   175.17	   175.17	  HIV/AIDS	   124.43	   163.77	  Other	  Skin	  Disease	   124.23	   124.23	  Other	  Gastrointestinal	  Disease	  	   112.72	   112.72	  Common	  Cold	   106.56	   106.56	  Nose	  or	  Throat	  Disease	   81.32	   81.32	  Diarrhea	  without	  Blood	   79.04	   79.04	  Other	  Eye	  Disease	   61.24	   61.24	  Uro-­‐Genital	  Case	  (Not	  STI)	   46.54	   46.54	  Dental	  Disease	   41.25	   41.25	  Vaginal	  Discharge	   0	   31.33	  Ear	  Disease	   27.47	   27.47	  Hypertension	   24.84	   24.84	  Neurological	  Disease	   24.15	   24.15	  Conjunctivitis	   22.58	   22.58	  Other	  STI	  Disease	   20.47	   20.47	  	  The	  pairings	  used	  to	  calculate	  the	  in/outpatient	  ratio	  and	  hospital	  stays	  are	  shown	  below	  in	  Table	  E.2.	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Table	  E.2:	  Assumptions	  used	  in	  Inpatient	  &	  Outpatient	  Morbidity	  Pairings	  Inpatient	  Morbidity	  Causes	   Outpatient	  Morbidity	  Causes	  1. Other	  musculoskeletal	  or	  connective	  tissue	  disorders/procedures	   1. Musculoskeletal	  system	  disorder	  2. Other	  respiratory	  system	  disease,	  pneumoconiosis,	  lung	  abscess,	  etc.	   2. Other	  respiratory	  disease	  diagnoses	  3. Other	  diseases	  or	  procedures	  on	  skin,	  subcutaneous	  tissue	   3. Other	  skin	  disease	  diagnoses	  4. Diarrhea,	  gastroenteritis,	  presumed	  infectious	   4. Diarrhea	  without	  blood	  5. Other	  urinary	  system,	  including	  bladder	  diseases,	  UTI,	  urethral	  stricture	   5. Uro-­‐genital	  case	  (not	  STI)	  6. Schizophrenia	  and	  delusional	  disorders	   6. Neurological	  disease/disorder	  7. Hypertension,	  essential	  	   7. Hypertension	  8. HIV	  disease	  (AIDS)	   8. HIV	  clinical	  diagnosis	  	  The	  in/outpatient	  ratio	  is	  provided	  for	  each	  pairing	  in	  table	  E.3.	  We	  did	  not	  enter	  a	  value	  in	  the	  model	  for	  the	  health	  problems	  that	  did	  not	  correspond	  with	  inpatient	  health	  problems.	  	  
Table	  E.3	  Inpatient	  to	  Outpatient	  Relative	  Proportions	  
Disease	   Inpatient/Outpatient	  Ratio	  Musculoskeletal	  system	  disorder	   0.00094	  Other	  respiratory	  disease	  diagnoses	  	   0.00122	  Other	  skin	  disease	  diagnoses	   0.00341	  Diarrhea	  without	  blood	  	   0.01131	  Uro-­‐genital	  case	  (not	  STI)	   0.01063	  Neurological	  disease/disorder	   0.04169	  Hypertension	  	   0.03182	  HIV	  clinical	  diagnosis	   0.11984	  	  The	  average	  length	  of	  hospital	  stay	  in	  days	  is	  given	  for	  in	  table	  E.4.	  For	  the	  health	  categories	  that	  matched	  in	  Table	  E.2	  the	  MoHSS	  inpatient	  hospital	  stay	  data	  was	  used.	  For	  the	  remaining	  health	  problems	  we	  referenced	  the	  hospital	  stay	  values	  in	  Ghana’s	  cost-­‐benefit	  projection	  model	  and	  made	  rough	  estimates.	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Table	  E.4:	  Average	  Length	  of	  Hospital	  Stays	  for	  top	  Causes	  of	  Morbidity	  	  Cause	  of	  Morbidity	   Average	  Length	  of	  Hospital	  Stay	  in	  Days	  Musculoskeletal	  System	  Disorder	   6.52	  Other	  Respiratory	  Disease	   5.89	  Trauma	   5.74	  Other	  Skin	  Disease	   8.31	  Other	  Gastrointestinal	  Disease	  	   5.32	  Common	  Cold	   1	  Nose	  or	  Throat	  Disease	   3.6	  Diarrhoea,	  Gastrointentritis	   6.66	  Other	  Eye	  Disease	   7.1	  Uro-­‐Genital	  Case	  (Not	  STI)	   5.69	  Dental	  Disease	   0.5	  Vaginal	  Discharge	   0.5	  Ear	  Disease	   4.2	  Hypertension	   6.54	  Neurological	  Disease	   12.5	  Conjunctivitis	   2	  Other	  STI	  Disease	   3.8	  HIV/AIDS	   10.96	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Appendix	  F:	  Risk	  Factors	  and	  Annual	  Unproductive	  Days	  Included	  in	  Appendix	  F	  are	  the	  two	  groups	  of	  risk	  factors	  identified	  by	  the	  WHO	  (Table	  F.1)	  and	  from	  PharmAccess	  (Table	  F.2).	  The	  data	  are	  presented	  as	  decimal	  percentages,	  which	  are	  proportions.	  To	  convert	  to	  a	  percentage,	  multiply	  the	  value	  in	  the	  table	  by	  100.	  
Table	  F.1:	  WHO	  Risk	  Factor	  Percentages	  for	  Males	  and	  Females	  
Risk	  Factor	   Decimal	  Percentage	  for	  Males	   Decimal	  Percentage	  for	  Females	  Physical	  Inactivity	   0.519	   0.651	  Raised	  Blood	  Pressure	   0.510	   0.469	  Alcohol	  Consumption	   0.413	   0.200	  Overweight	  BMI	   0.233	   0.447	  Daily	  Tobacco	  Use	   0.216	   0.069	  Raised	  Blood	  Glucose	   0.071	   0.085	  Raised	  Cholesterol	   0.062	   0.082	  
	  
Table	  F.2:	  PharmAccess	  Risk	  Factor	  Percentages	  for	  Males	  and	  Females	  
Risk	  Factor	   Decimal	  Percentage	  for	  Males	   Decimal	  Percentage	  for	  Females	  High	  Blood	  Pressure	   0.104	   0.008	  High	  BMI	   0.214	   0.295	  Hypoglycemic	   0.4155	   0.6783	  Hyperglycemic	   1.0173	   0.6783	  	  	  We	  determined	  the	  number	  or	  annual	  unproductive	  days	  for	  the	  risk	  factors	  included	  in	  the	  model	  by	  referring	  to	  a	  study	  done	  on	  presenteeism	  in	  the	  United	  States.	  The	  estimates	  are	  listed	  in	  Table	  F.3.	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Table	  F.3:	  Annual	  Unproductive	  Days	  for	  Males	  and	  Females	  
Risk	  Factor	   Annual	  Unproductive	  Days	  for	  
Males	  
Annual	  Unproductive	  Days	  for	  
Females	  Raised	  Cholesterol	   0.730	   0.880	  Raised	  Blood	  Pressure	   0.730	   0.880	  Alcohol	  Consumption	   1.340	   1.650	  Overweight	  BMI	   0.730	   0.880	  Daily	  Tobacco	  Use	   1.340	   1.65	  Abnormal	  Glucose	  Levels	   0.730	   0.880	  Underweight	  BMI	   0.730	   0.880	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Appendix	  G:	  WHO-­‐CHOICE	  Interventions	  	  
Table	  G.1:	  WHO-­‐CHOICE	  Interventions	  for	  HIV/AIDS	  
Code	   Interventions	   %	  Coverage	   Cost	  	  per	  person	  N$	  
HIV-­‐7	   Mass	  Media	  (MED)	   100%	   0.45	  
HIV-­‐13	   Treatment	  of	  sexually	  transmitted	  Infections	  (STI)	   95%	   5.89	  
HIV-­‐14	   Voluntary	  counseling	  &	  testing	  (VCT)	   95%	   10.54	  
HIV-­‐15	   Prevention	  of	  Mother	  to	  Child	  Transmission	  (PMTCT)	   Antenatal	  Care	  Coverage	   4.20	  
HIV-­‐16	   Highly	  Active	  Anti-­‐Retroviral	  Therapy	  (HAART),	  simple	   Antenatal	  Care	  Coverage	   34.92	  
HIV-­‐18	   HAART	  Plus	  (interleukin	  2)	   Antenatal	  Care	  Coverage	   166.28	  	  	  
Table	  G.2:	  WHO-­‐CHOICE	  Interventions	  for	  Tuberculosis	  
Code	   Interventions	   %	  Coverage	   Cost	  per	  person	  N$	  
TB-­‐9	   SmearPos:	  Treatment	  of	  new	  smear-­‐positive	  cases	  only	  under	  DOTS	   95%	   9.55	  
TB-­‐10	   SmearPosNeg:	  As	  for	  SmearPos,	  plus	  treatment	  of	  smear-­‐negative	  cases	  under	  DOTS	   95%	   15.98	  
TB-­‐11	   SmearPosMDR:	  As	  for	  SmearPos,	  plust	  DOTS-­‐plus	  treatment	   95%	   12.86	  
TB-­‐12	  
	  
Combination:	  As	  SmearPos,	  plus	  DOTS	  treatment	  of	  smear-­‐negative	  cases	  plus	  DOTS-­‐plus	  standardized	  second-­‐time	  drug	  re-­‐treatment	  
95%	   19.20	  
	  
Table	  G.3:	  WHO-­‐CHOICE	  Interventions	  for	  HIV/AIDS	  and	  Tuberculosis	  Combination	  
Code	   Interventions	   %	  Coverage	   Cost	  per	  person	  N$	  
HIV-­‐17	   HAART	  (simple)	  &	  DOTS	  for	  TB	   n/a	   38.93	  
HIV-­‐19	   HAART	  Plus	  and	  DOTS	  for	  TB	   n/a	   179.49	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Table	  G.4:	  WHO-­‐CHOICE	  Interventions	  for	  Alcohol	  Consumption	  
Code	   Interventions	   %	  Coverage	   Cost	  per	  person	  N$	  
ALC-­‐2	   Brief	  PHC	  Advice	   50%	   3.48	  
ALC-­‐3	   Random	  Breath	  Testing	   80%	   1.79	  
ALC-­‐9	   Combination	  (ALC2	  +	  ALC3)	   n/a	   5.00	  	  	  
Table	  G.5:	  WHO-­‐CHOICE	  Interventions	  for	  Tobacco	  Use	  
Code	   Interventions	   %	  Coverage	   Cost	  per	  person	  N$	  
TOB-­‐5	   Clean	  indoor	  air	  law	  enforcement	   	  n/a	   2.32	  
TOB-­‐6	   Comprehensive	  advertise	  banning	   	  n/a	   0.98	  
TOB-­‐7	   Information	  dissemination	   	  n/a	   1.87	  
TOB-­‐8	   Nicotice	  replacement	  therapy	   	  n/a	   15.72	  	  	  
Table	  G.6:	  WHO-­‐CHOICE	  Interventions	  for	  Schizophrenia	  
Code	   Interventions	   Coverage	   Cost	  per	  person	  N$	  
SCZ-­‐1	   Older	  "neuroleptic"	  anti-­‐psychotic	  drug	   80%	   7.23	  
SCZ-­‐2	   Newer	  "atypical"	  anti-­‐psychotic	  drug	   80%	   27.32	  
SCZ-­‐3	   Older	  anti-­‐psychotic	  +	  psychosocial	  treatment	   80%	   7.86	  
SCZ-­‐4	   Newer	  anti-­‐psychotic	  +	  psychosocial	  treatment	   80%	   28.04	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Appendix	  H:	  Data	  Request	  Form	  for	  the	  Epidemiological	  Profile	  	  	  	  	  	  Data	  Request	  Form	  	  The	  following	  data	  is	  being	  collected	  to	  develop	  NABCOA’s	  cost-­‐benefit	  projection	  model.	  The	  data	  must	  be	  gender-­‐specific	  and	  age-­‐specific.	  	  1.	  Top	  30	  causes	  of	  mortality	  
• Number	  of	  deaths	  reported	  in	  a	  year	  for:	  
o Males	  18-­‐59	  
o Females	  18-­‐59	  	  2.	  Top	  50	  causes	  of	  morbidity	  
• Number	  of	  new	  cases	  reported	  in	  a	  year	  for:	  
o Outpatient	  cases	  
§ Males	  18-­‐59	  
§ Females	  18-­‐59	  
o Inpatient	  Cases	  	  
§ Males	  18-­‐59	  
§ Females	  18-­‐59	  
• Length	  of	  hospital	  stay	  in	  days	  for	  inpatient	  cases	  	  3.	  Top	  10	  risk	  factors	  
• Percentages	  for:	  
o Males	  18-­‐59	  
o Women	  18-­‐59	  
• Annual	  unproductive	  days	  for	  each	  risk	  factor	  	  	  
	  	  	  	  	  
